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 PAR proteinase activated receptor 
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PLC phospholipase C 
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Trk A neurotrophic tyrosine kinase receptor type 1/ high affinity nerve growth factor receptor/ 
TRK1-transforming tyrosine kinase protein 
TRP transient receptor potential 
TRPA1 transient receptor potential cation channel, subfamily A, previously:  Transient 
receptor potential ankyrin type 
TRPM8 transient receptor potential cation channel, subfamily M, member 8  
TRPV transient receptor potential vanilloid type 
VIP vasoactive intestinal polypeptide 
VMA vanillin mandelic acid 
VR vanilloid receptor
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INTRODUCTION 
 
Capsaicin, chemosensitive primary sensory neurons and TRP channels 
Capsaicin is the pungent component of capsicum species (hot chili peppers) that 
selectively excites and, in large doses selectively desensitizes a subpopulation of primary 
sensory neurons. Nicholas Jancsó’s classical studies have revealed that application of 
capsaicin onto the skin, conjunctiva, or other mucous membranes induces intense burning 
pain in man (Jancsó, 1960; Jancsó et al., 1967), and elicits pain-related behavior and 
nociceptive reflexes in animals.  Jancsó has also recognized that these fibers possess dual 
function: they have a role not only in the signalization of pain, but also in the mechanism of 
local vascular responses. Hence, local application of chemical irritants, such as capsaicin and 
mustard oil, produces not only burning pain but local vasodilatation and flare in man, and 
local vasodilatation and plasma extravasation, i.e. a neurogenic inflammatory response in rats 
(Jancsó, 1960; Jancsó et al., 2009a). The term „capsaicin desensitization” was first introduced 
by N. Jancsó (Jancsó and Jancsó-Gábor, 1959; Jancsó, 1968; Holzer, 1991; Jancsó, 1994). He 
observed that repeated local or systemic administration of capsaicin inhibited not only the 
transmission of afferent nociceptive impulses, but also the efferent vascular responses 
mediated by chemosensitive afferent nerves, both in man and animals. Capsaicin 
desensitization also inhibited the pain-producing effect of other irritants of widely different 
chemical structure, like xylene, mustard oil or chloroacetophenone, while mechano-
nociceptive reflexes remained intact (Jancsó and Jancsó-Gábor, 1959; Jancsó et al., 1968). 
Capsaicin-sensitive neurons comprise a special, quantitatively and functionally 
important population of somatic and visceral primary sensory neurons. The knowledge on the 
morphological characteristics, anatomical organization and functions of these nociceptive 
primary afferent neurons was greatly advanced by the discovery of the selective neurotoxic 
action of capsaicin by G. Jancsó and his co-workers (Jancsó et al., 1977; Jancsó and Király, 
1981; Jancsó and Király, 1984). Systemic administration of capsaicin to new-born rats led to a 
selective degeneration of about 50% of sensory ganglion cells. In peripheral cutaneous nerves 
a 70 % loss of unmyelinated C fibers was observed (Jancsó et al, 1977). In lumbar dorsal 
roots an about 95% loss of C-, and about a 10% loss of thin myelinated A-fibers was reported 
after neonatal capsaicin treatment (Jancsó et al., 1981; Jancsó and Király, 1981; Nagy et al., 
1981). Different types of systemic and regional treatments with capsaicin or other vanilloids 
have become standard techniques in pain research to reveal the participation of 
 2 
chemosensitive primary afferent neurons in different somatic and visceral functions under 
physiological and pathological conditions.  
In 1997 Caterina and his co-workers successfully cloned the capsaicin receptor 
(Caterina et al., 1997; Caterina and Julius, 2001). The cloning of the receptor was based on an 
expression screening strategy exploiting the phenomenon of capsaicin-induced increase in 
intracellular free calcium (Jancsó et al., 1978; Joó et al., 1980; Jancsó et al., 1984)  The 
capsaicin receptor was first named vanilloid receptor type 1 (VR1). Later, it has been 
recognized that this receptor highly resembles the transient receptor potential (TRP) ion 
channels (Caterina et al., 1997). These results were published in Nature by Michael Caterina 
50 years after the publication of N. Jancsó’s article in Nature in 1947, explaining the 
phenomenon of histamine desensitization) (the idea that finally brought him to the recognition 
of capsaicin desensitization (Jancsó and Jancsó-Gábor, 1947; Jancsó, 1994; Jancsó and 
Sántha, 2015), and 20 years after the discovery of the selective neurotoxic action of capsaicin 
by Gábor Jancsó published in Nature in 1977 (Jancsó et al., 1977). The TRP (transient 
receptor potential) family of ion channels comprises more than 30 ion channels, and can be 
divided into seven subfamilies based on their sequence homology. In the case of the TRP 
channels, polymodality lies in a single channel. TRP channels are multifunctional sensors of 
chemical, mechanical and thermal stimuli. TRPV1, TRPV2, TRPV3, TRPV4, TRPM8 (transient 
receptor potential cation channel, subfamily M, member 8, previously melastatin type 8) and 
TRPA1 (transient receptor potential cation channel, subfamily A, previously: ankyrin type) are 
known to be expressed in dorsal root ganglia (DRGs) neurons. So far TRPV1 is the only 
known receptor that is responsive to capsaicin. The molecular site of the desensitizing effect 
of capsaicin is located on the sixth transmembrane domain. TRPV1 is present in the cell 
membrane, in the endoplasmic reticulum, and in cytoplasmic vesicles (Guo et al., 1999; 
Morenilla-Palao et al., 2004; Nagy and Sántha, 2008). It is synthetized in the soma of the 
neuron, packaged and transported by fast axonal transport into the central and peripheral 
terminals of the neurons to fulfill its function in sensory conduction.  
The fact that capsaicin applied topically onto peripheral nerves resulted in a selective 
loss of neurogenic plasma extravasation (Jancsó et al., 1980; Gamse et al., 1982; Dux et al., 
1999) increase in heat pain threshold (Jancsó et al., 1980; Fitzgerald and Woolf, 1982), and 
inhibition of reactive hyperemia (Domoki et al., 2003) suggested the presence of functioning 
capsaicin receptors in peripheral sensory axons. Perineural application of capsaicin resulted in 
a blockade of axoplasmic transport of neurotransmitter peptides (Gamse et al., 1982), a 
selective and permanent reduction of both afferent sensory (heat- and chemo nociception), 
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and efferent regulatory (neurogenic inflammation) functions, and lead to a dramatic loss of 
epidermal fibers in the skin area which is innervated by the treated nerve. (Dux and Jancsó, 
1994) The peripheral axon is not only a transporting route for the TRPV1 receptors, 
functioning receptors are also present in the axonal membrane, although their 
physiological/pathophysiological role need to be clarified (Tominaga et al., 1998). TRPV1 is 
expressed in about 30-60% of rat DRG neurons with considerable variations with respect to 
spinal segmental levels (Tominaga et al., 1998; Michael and Priestley, 1999; Malin et al., 
2011). TRPV1 is expressed almost exclusively in small- and medium-sized neurons with 
polymodal nociceptive function. These results are in accordance with earlier findings on 
sensory nerve fiber and ganglion cell loss after systemic neonatal capsaicin treatment (Jancsó 
et al., 1977; Nagy et al., 1983; Lawson, 1987). Small and medium-sized nociceptive DRG 
neurons can be divided into two main, partially overlapping populations. Peptidergic DRG 
neurons are characterized by the constitutive expression of several neuropeptides, especially 
calcitonin gene-related peptide (CGRP), substance P (SP) and somatostatin (Kruger et al., 
1989; Lawson, 1995), contain neurotrophic tyrosine kinase receptor type 1 (trkA), respond to 
nerve growth factor (NGF) in the adult rat and comprise about 40% of DRG neurons. Non-
peptidergic DRG neurons bind the Bandeiraea simplicifolia isolectin B4 (IB4), contain 
thiamine monophosphatase (TMP), respond to GDNF and make up about 30% of small DRG 
neurons. TRPV1 is expressed in the majority of both peptidergic (60% is TRPV1-positive) and 
non-peptidergic (75% is TRPV1-positive) neurons. TRPV1 is expressed only in few large and 
medium-sized DRG neurons with myelinated axons that express the 200 kD neurofilament 
(Michael and Priestley, 1999). 
Early studies by N. Jancsó (Jancsó, 1960; Jancsó et al., 1968) demonstrated that 
besides capsaicin-type compounds, mustard oil (allyl-isothiocyanate) also stimulates 
chemosensitive afferent nerves and elicits neurogenic inflammation. The phlogogenic effect 
of mustard oil, similarly to capsaicin, was completely abolished by denervation, capsaicin 
desensitization of adult rats (Jancsó et al., 1967) neonatal treatment with capsaicin (Jancsó et 
al., 1977) indicating the mediation of mustard oil-induced vascular reactions by 
chemosensitive afferent nerves. Similarly, perineural application of capsaicin produced a 
permanent loss of mustard oil-induced vascular reactions in the innervation area of the 
capsaicin-treated nerve (Jancsó et al., 1980). Further, mustard oil- but not capsaicin-induced 
neurogenic inflammation could be elicited in TRPV1
-/-
 mice, indicating the existence of 
another TRP receptor (Caterina et al., 2000; Bánvölgyi et al., 2004). Experiments on rodents 
confirmed that a large population of TRPV1-positive neurons are also responsive to mustard 
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oil (Story et al., 2003; Jordt et al., 2004), and express the TRPA1 receptors (Kobayashi et al., 
2005; Nagata et al., 2005; Bautista et al., 2006). Besides mustard oil, TRPA1 can be activated 
by cinnamaldehyde (in cinnamon), allicin (in garlic), methyl salicylate (in wintergreen oil), 
gingerol (in ginger), eugenol (in clove oil) and bradykinin. The data on its role in cold-
nociception are controversial (Story et al., 2003; Macpherson et al., 2005; Mckemy, 2005).  
Both somatic and visceral afferents involve a large chemosensitive population. They 
innervate, inter alia, the skin, the airways, the cardiovascular system, the gastro-intestinal 
tract, the urogenital system, the dura mater and have essential role in chemo-nociception and 
in a number of organ-specific local physiological and pathological events (Jancsó, 1960; 
Jancsó et al., 1968; Jancsó, 1984; Maggi et al., 1984; Jancsó et al., 1985; Rózsa et al., 1986; 
Jancsó et al., 1987; Holzer, 1998a; Holzer, 1998b; Dux et al., 2003). Neurogenic 
inflammation, the most thoroughly studied local regulatory process, is essential in the 
modulation of local blood flow, vascular permeability, inflammatory processes and tissue 
defense mechanisms in many organs (Jancsó, 1960; Jancsó et al., 1968; Rózsa et al., 1986; 
Maggi et al., 1987; Brain, 1997; Holzer, 1998a; Holzer and Holzer-Petsche, 2001; Jancsó, 
2009; Jancsó et al., 2009a). Besides their organ- or tissue-specific characteristics, visceral and 
somatic chemosensitive afferents share many common traits in terms of their morphology, 
neurochemistry and function. The cutaneous chemosensitive afferent nerves are the best-
characterized class of this particular population (Roosterman et al., 2006; Jancsó et al., 
2009b). 
 
Chemosensitive innervation of the skin with special regard to neurogenic inflammation and 
inflammatory hyperalgesia 
The skin has a remarkably rich TRPV1 positive innervation. Perineural treatment of rat 
peripheral nerves led to a loss of about 30% of cutaneous afferents (Jancsó and Lawson, 1990; 
Pini et al., 1990), and about 80% loss of epidermal nerves (Dux and Jancsó, 1994), an almost 
complete loss of SP-immunoreactive epidermal fibers and a less pronounced decrease of 
CGRP-immunoreactive axons (Dux and Jancsó, 1999). According to the results of Dux and 
co-workers, perineural capsaicin treatment resulted in a dramatic loss of intraepidermal nerves 
in skin areas innervated by the treated nerve: they found that 90% of nerves stained with the 
PGP 9.5 antiserum, a panneuronal marker, disappeared from the epidermis already three days 
after perineural capsaicin treatment (Dux et al., 1999). Repeated topical application of 
capsaicin onto the skin resulted in a temporary hypalgesia and loss of epidermal fibers in rats 
(Orosz et al., 1998) and also in man (Nolano et al., 1999).  
 5 
Structural difference between peptidergic and non-peptidergic fibers was first 
described by Dux and coworkers (Dux et al., 1999) who showed that epidermal axons with 
simple morphology are peptidergic and those with a complex morphology are non-
peptidergic. Zylka et al. (2005) showed that in mice peptidergic and non-peptidergic 
epidermal nerve endings terminate in different epidermal layers (CGRP+ fibers appeared to 
end in the stratum spinosum and non-peptidergic fibers seemed to penetrate into the stratum 
granulosum); he also realized that peptidergic and non-peptidergic fibers had different 
morphology, peptidergic were straight and non-peptidergic had a zig-zag structure as 
described earlier by Dux et al. (1999).  
Cutaneous TRPV1-positive fibers primarily act as polymodal nociceptors that are 
responsible for heat- and chemo-nociception. Besides transmitting nociceptive impulses 
towards the central nervous system, these sensory neurons release peptides from their 
peripheral endings, and maybe along their peripheral axons, in response to noxious stimuli. 
Sensory neuropeptides such as CGRP, SP or neurokinin A (NKA) released from the activated 
nociceptors mediate local regulatory functions involving the microvasculature, inflammatory- 
and dermal/epidermal cells and the sensory neurons themselves. Among the local regulatory 
roles of sensory neurons, the vascular changes associated with sensory nerves were 
recognized even before the exact identification of the mediators. The triple response of the 
human skin evoked by noxious stimuli of different modalities was observed by Lewis (Lewis 
and Grant, 1924). It is composed of local vasodilatation, edema formation (wheal), and 
spreading vasodilatation (flare). In rats, the flare response is missing. Because the classical 
signs of inflammation, „rubor, tumor cum dolore et calore” were present in the reaction 
induced by noxious stimuli at least in humans, and because the existence of a substantial 
neurogenic component was evident, N. Jancsó named it „neurogenic inflammation” (Jancsó, 
1960). In the human skin the sensory fibers mediating the flare response are chemosensitive 
(Jancsó, 1960; Jancsó et al., 1968; Jancsó et al., 1985) and mechano-insensitive C-fibers 
(Schmelz et al., 2000). In the rat, sensory vasodilatation is primarily mediated by capsaicin-
sensitive C-fibers, but activation of Aδ fibers might also cause vasodilatation (Kenins, 1981; 
Lynn et al., 1996). While cutaneous vasodilatation and flare responses could be elicited by 
relatively mild chemical, physical or electrical stimuli, the production of neurogenic plasma 
extravasation requires excessive stimulation. Substance P (SP) was the first peptide verified 
as a mediator of sensory neurogenic vascular responses (Lembeck and Holzer, 1979; Gamse 
et al., 1980). It is a member of the tachykinin group together with the structurally similar 
NKA and B. SP causes plasma extravasation by binding to the NK1 receptor (a G protein 
 6 
coupled receptor) situated on endothelial cells of postcapillary venules (Lembeck and Holzer, 
1979; Kenins, 1981; Kenins et al., 1984; Chahl, 1988). SP also activates cutaneous mast cells 
(Bueb et al., 1990; Holzer, 1992) and sensitizes nociceptors (Li et al., 2012). Calcitonin gene 
related peptide (CGRP) is a sensory neuropeptide which is found in both small and large 
primary afferent neurons (Kruger et al., 1989). CGRP is a member of the calcitonin (CALC) 
superfamily: a group of mainly hormokine peptides that derive from the CALC genes. CGRP 
I (or α) is a 37 amino acid long alternative mRNA splice product of the CALC I gene, 
together with calcitonin and pro-calcitonin. CALC II leads to CGRP II (or ß, which differs in 
3 amino acids from CGRP I or α), and CALC IV and V give rise to amylin and 
adrenomedullin, respectively, while CALC III is a non-translated pseudogene. Based on their 
structural homologies, calcitonin peptides have overlapping bioactivities, which they exert by 
binding to the same family of receptors. There are two subgroups of these G protein-coupled 
receptors with seven transmembrane domains: CALC receptors and calcitonin receptor-like 
receptor (CLR). Three accessory proteins, receptor activity-modifying proteins (RAMPs 1–3), 
bind to these receptors and alter their specific responsiveness and ligand affinity (Russell et 
al., 2014). The presence, the concentration, and the timing of the three RAMPs determines the 
specific cellular phenotype of the receptor that is biologically active on the cell surface 
(Christ-Crain and Müller, 2007). CGRP-immunoreactive fibers are more numerous in the 
human and rat skin than SP immunoreactive ones (Wallengren et al., 1987; Dux et al., 1999). 
In rodent as well as in human sensory nerves, CGRP is, at least in part, colocalized with 
substance P (Gibbins et al., 1985; Franco-Cereceda et al., 1987). It is a very potent vasodilator 
in the skin in many animals and in man (Brain et al., 1985). CGRP exerts its vasodilatory 
effect by directly acting on vascular smooth muscle cells (Ralevic et al., 1992) and also by 
activating endothelium-dependent NO pathways (Brain and Grant, 2004).  
Both peptides are transported into the nerve endings via fast axonal transport (Morton 
and Chahl, 1980; Gamse et al., 1982) where they are stored and can be released via TRPV1 or 
TRPA1 mediated mechanisms (Pethő et al., 2004; Bautista et al., 2006). CGRP can also be 
released from isolated peripheral nerves via TRPV1-mediated mechanisms (Bernardini et al., 
2004). Electrophysiological studies in vivo suggested a role for CGRP in regulating thermal 
sensitivity, sensitization and ectopic spike generation in peripheral nociceptive axons 
(Hoffmann et al., 2008). Some other neuropeptides expressed by cutaneous sensory neurons 
include pituitary adenylate cyclase-activating polypeptide (PACAP), vasoactive intestinal 
polypeptide (VIP), somatostatin (SOM) (Wallengren et al., 1987), and galanin (GAL) (Bártfai 
et al., 1992; Hokfelt et al., 1994; Sántha et al., 1998a; Sántha et al., 1998b; Sántha et al., 
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1999).  In the periphery, the main source of histamine is the mast cell. Mast cell degranulation 
mainly occurs when a tissue is inflamed or allergens are present (Benditt et al., 1955). Many 
factors cause histamine release, so does SP in the human skin (Bunker et al., 1991). There are 
four known types of histamine receptors, all of them are coupled to G-proteins (Shim and Oh, 
2008). H1R is found on endothelial cells and on sensory nerve endings. Histamine-induced 
plasma extravasation (Jancsó and Jancsó-Gábor, 1947) is mediated by endothelial H1R and 
consequent PLC activation. Histamine also has a vasodilator effect via binding to H2Rs on 
vascular smooth muscle. Histamine has vasoactive and proinflammatory effects, but it does 
not appear to have an essential role either in the initiation or in the final vascular response of 
the neurogenic inflammation (Jancsó et al., 2009a). Bradykinin, the „slow” kinin is a 
nonapeptide, which is formed from HMW (high molecular weight) kininogen by the action of 
kallikrein and other substances. Bradykinin is a potent endothelium-dependent vasodilator, 
inflammatory mediator and pain-producing substance. There are two known bradykinin 
receptors: B1 and B2, both of them are G-protein coupled receptors. Activation of B1 receptor 
is responsible for neutrophil recruitment during inflammation, while endothelial B2 receptor is 
involved in the vasodilator activity. Bradykinin causes plasma extravasation in many tissues 
by a B2 receptor-mediated pathway (Hall, 1997). Bradykinin can be considered as an 
endogenous activator of the TRPV1 through B2 receptors (Vellani et al., 2004). Arachidonic 
acid derivatives, local release of proteinases and NO also increase the complexity of neuro-
vascular reactions. Neurogenic inflammation is not only a cutaneous phenomenon; it also 
appears in many other organs, including the airways, the urogenital system, several parts of 
the gastrointestinal tract and the dura mater (Saria et al., 1987; Maggi and Meli, 1988; Abelli 
et al., 1991; Dux et al., 2003; Klukovits et al., 2004). 
Cutaneous fibers that express the TRPV1 receptor are key players of sensitization that 
are initiated by inflammation or tissue injury and lead to hyperalgesia and allodynia (Fischer 
and Reeh, 2007; Watanabe et al., 2015).  Tissue damage and inflammation produce an array 
of chemical mediators such as ATP, bradykinin, prostanoids, protons, cytokines and peptides 
including substance P that can excite or sensitize nociceptors to elicit pain at the site of injury. 
Pain hypersensitivity can take two forms: hyperalgesia is when noxious stimuli produce an 
exaggerated and prolonged pain and allodynia is when thresholds are lowered so stimuli that 
normally don’t cause pain, become painful (Costigan and Woolf, 2000). Hypersensitivity may 
be of peripheral or central origin. Peripheral sensitization involves increased excitability of 
the nociceptive nerve terminal and begin very early, even within seconds after injury. Central 
sensitization evolves slower and implicate long term changes in the synaptic transmission in 
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the central pain pathway. Heat hyperalgesia is said to be a result of peripheral sensitization 
and mechanical allodynia is considered to be central. As both central and peripheral 
mechanisms are closely related to processes that take place in the primary sensory neuron as a 
sensory unit, clear-cut separation of peripheral and central sensitization might not be 
inevitable although it serves as a helpful model. Several experimental models exist for 
inflammatory hyperalgesia including those induced by formalin, Freund’s adjuvant and 
carrageenan (Hargreaves et al., 1988; Ren and Dubler, 1999; Gould, 2000).  Intraplantar 
injection of carrageenan in experimental animals causes paw edema, heat hyperalgesia and 
mechanical allodynia that develops in the inflamed area (Kocher et al., 1987; Hargreaves et 
al., 1988) and reaches its peak within four hours. In the pathomechanism of carrageenan-
induced hyperalgesia sensitization and up-regulation of the TRPV1 receptors play a crucial 
role and the NGF signalization pathway is involved (Sammons et al., 2000; Tohda et al., 
2001). Systemic neonatal capsaicin treatment significantly decreases the carrageenan-induced 
heat- and tactile hyperalgesia (Lee et al., 2004).   
Sensory denervation of the skin in humans and in experimental animals results in the 
development of cutaneous lesions, impaired wound-healing (Kishimoto, 2016), and decreased 
hair growth (Maggi et al., 1987; Thomas et al., 1994). Toxic effects and metabolic disorders 
that affect cutaneous sensory neurons often lead to impaired homeostasis and/or structural 
lesions of the skin.  Measurement of the efferent vascular functions (Jancsó and Janka, 1981) 
and morphological analysis of tissue samples (Beiswenger et al., 2008) are reliable methods 
for the detection of the structural and functional integrity of cutaneous nerves not only in 
experimental animals but in man, too. A quantitative assessment of the vascular reactions 
elicited through activation of TRPV1 and/or TRPA1 receptors localized on chemosensitive 
afferent nerves serves as a reliable indicator of the functional condition of these afferent 
nerves in both man and animals (Jancsó and Janka, 1981; Jancsó et al., 1985; Baron et al., 
1988; Lynn et al., 1996; Dux et al., 2003; Bernardini et al., 2004; Namer et al., 2005). Further, 
measurements of the capsaicin- or mustard oil-induced release of the sensory neuropeptide 
CGRP in ex vivo preparations provide valuable information on the functional integrity of 
chemosensitive afferent nerves (Gamse et al., 1980; Saria et al., 1987; Lundberg et al., 1992; 
Dux et al., 2007; Fuchs et al., 2010).  
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Sensory innervation of the heart and the protective role of peptidergic afferent nerves 
against cardiac injury  
In many cultures the heart is considered as the center of emotions, but what we really 
sense with our heart, is not an easy issue. As for non-painful sensations, everybody can sense 
palpitation, extrasystole and arrhythmia. Interestingly, many pathologies of the heart, 
including myocarditis or rupture of the valves do not lead to sensation of cardiac pain 
(Malliani et al., 1986). Ischemic pain of the heart is the most common cardiac pathology 
associated with the activation of cardiac nociceptors. Cardiac chemo-nociceptive nerve 
endings can be activated by hypoxia, acidity, and potassium ions. Importantly, cardiac 
sensory nerves may respond to these stimuli with the release of sensory neuropeptides such as 
CGRP or SP (Franco-Cereceda et al., 1987; Holzer, 1992; Sosunov et al., 1996; Nagy et al., 
2004).  
The existence of sensory endings in the heart was first suggested by Berkley (1894), 
Smirnov (1895)), and Dogiel (1898). An excellent monograph on the innervation of the heart 
and the blood vessels has been published by (Ábrahám, 1969). Anatomically, the heart 
receives dual sensory innervation. Nociceptive spinal afferent nerves, whose parent cell 
bodies are located in the thoracic DRGs 1-6, run together with postganglionic sympathetic 
fibers. Vagal afferent nerves, whose parent cell bodies are situated in the nodose ganglion, 
join vagal parasympathetic fibers. The relative contribution of vagal and spinal sensory nerves 
to the innervation of the heart is controversial. Langley (1903) stated, that most of the afferent 
fibers, the stimulation of which leads to pain, run with the sympathetics and are of spinal 
origin. Woollard (1926) suggested, that a large proportion of cardiac sensory nerves are of 
vagal origin. Nettleship (1936) came to a different conclusion by showing that removal of 
thoracic DRGs resulted in the degeneration of nerves innervating the apical ventricular 
endocardium and the coronary arteries. Khabarova (1963) observed that vagal and spinal 
endings frequently run side by side. Vagal afferents form plexi associated with cardiac 
ganglia, where they provide dense pericellular ending on the small intensely fluorescent (SIF) 
cells. In the myocardium afferents are in close contact with the cardiac muscle and conduction 
fibers, and in the endocardium they form end-net or flower spray terminals. Some fibers have 
both endocardial and myocardial intramuscular endings (Cheng et al., 1997).   
Vagal left ventricular receptors are C-fiber afferents that mediate the Bezold-Jarish 
reflex. Bezold reported the cardiodepressive reflex evoked by veratrum alkaloids (von Bezold 
and Hirt, 1867) and Jarish clarified the reflex (Jarish and Henze, 1937).  According to 
(Hainsworth, 1991), the receptors involved in the Bezold-Jarisch reflex respond to bradykinin, 
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prostaglandins, capsaicin, serotonin and phenylbiguanidine (PBG). Jancsó and Such (1986) 
demonstrated in cats that perivagal capsaicin treatment greatly reduced i.v. capsaicin-induced 
reflex bradycardia, hypotension and apnea but left these reflex responses evoked by 
intravenous administration of PBG and veratrine unaffected. These findings indicated that 
vagal afferent fibers mediating cardiovascular and respiratory chemo-reflexes are separated 
into chemo-specifically different populations.  
A large population of cardiac sensory nerves is sensitive to capsaicin (Jancsó and 
Such, 1983; Ferdinandy et al., 1997). Several studies concluded that capsaicin induces 
positive chronotropic and inotropic effects in the isolated guinea pig atrium (Fukada and 
Fujiwara, 1969;  et al., 1969; Lundberg et al., 1984). It was also shown that in guinea pig 
whole-heart preparations, CGRP stimulates the rate and force of atrial contractions (Franco-
Cereceda and Lundberg, 1988). Franco-Cereceda and coworkers furnished indirect evidence 
that activation of cardiac nerves by capsaicin results in the release of CGRP, which is at least 
partly responsible for the capsaicin-evoked cardiac effects. In the isolated guinea-pig right 
atrium capsaicin (10-6 M) evoked an increase in contractile rate and tension with a 
simultaneous outflow of CGRP-LI. In the isolated whole heart, capsaicin increased the 
outflow of CGRP-LI and stimulated heart rate while a negative inotropic effect was observed. 
The negative inotropic effect of capsaicin is unrelated to the activation of sensory nerves 
(Franco-Cereceda et al., 1991).  
Application of capsaicin (10µg/ml) onto the epicardial surface of the left ventricle in 
anaesthetized rats resulted in cardiogenic sympathoexcitatory response (Zahner et al., 2003) 
similar to that induced by bradykinin (Baker et al., 1980; Veelken et al., 1996; Tjen-A-Looi et 
al., 1998; Li and Pan, 2000; Pan and Chen, 2002). Capsaicin and bradykinin seem to act on 
the same subpopulation of neurons, but on different receptors, TRPV1 and B2, respectively.  
The study of the involvement of cardiac sensory nerves in the development of cardiac 
pathologies is a rapidly growing field of cardiovascular research. CGRP is to be found in 
approximately 40% of primary sensory neurons, including those innervating the heart 
(Gibbins et al., 1985; Mulderry et al., 1985; Franco-Cereceda et al., 1987; Franco-Cereceda 
and Lundberg, 1988). CGRP-containing nerves are present in all regions of the rat heart, 
especially in association with the coronary arteries, the papillary muscles, and the sinoatrial 
and atrioventricular nodes (Mulderry et al., 1985). The atria have a denser CGRP-positive 
innervation then the ventricles. CGRP immunopositive nerve fibers also occur in the cardiac 
ganglia between ganglion cells. In the guinea pig, most of the CGRP-positive fibers display 
SP immunopositivity, but in the rat, CGRP containing cardiovascular nerves are far more 
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numerous than those containing SP (Wharton et al., 1986). CGRP exerts marked coronary 
vasodilatory (Holman et al., 1986) and positive inotropic and chronotropic effects in several 
species (Franco-Cereceda and Lundberg, 1988; Franco-Cereceda and Lundberg, 1989; Yaoita 
et al., 1994; Gasparetti et al., 2002). CGRP is localized in cardiac primary sensory neurons 
which are sensitive to the potent sensory neurotoxin capsaicin (Franco-Cereceda and 
Lundberg, 1988; Ferdinandy et al., 1997; Gasparetti et al., 2002) and which express the 
TRPV1 receptor (Zahner et al., 2003). Systemic administration of capsaicin results in a 
depletion of CGRP from cardiac nerves (Ferdinandy et al., 1997), and a decrease in basal NO 
synthesis in the rat heart (Csont et al., 2003). It has been demonstrated that the depletion of 
CGRP by capsaicin results in a marked increase in the incidence of adverse reactions, which 
commence following the experimental induction of myocardial ischemia (Franco-Cereceda 
and Lundberg, 1989; Kallner, 1989; Kallner and Franco-Cereceda, 1989). Further, CGRP is 
essential for the development of myocardial protection: the depletion of CGRP from sensory 
nerves by prior pre-treatment with capsaicin greatly inhibits or even abolishes the protective 
effect of ischemic preconditioning (Ferdinandy et al., 1997; Zhou et al., 1999) or heat stress 
on reperfusion injury (Song et al., 1999), and attenuates the nitroglycerine-induced 
improvement of preservation with cardioplegic solution (Zhou et al., 2001). TRPV1 gene 
knockout impairs postischemic recovery (Wang and Wang, 2005) and N-oleoyldopamine, an 
endogenous activator of the TRPV1 receptor has been shown to protect the heart against 
ischemia-reperfusion injury (Zhong and Wang, 2008). CGRP seems to play an important role 
in both local (when conditioning stimulus is applied on the same organ), and remote (when 
stimulus is applied to a distant organ or tissue) ischemic conditioning (Wolfrum et al., 2005; 
Veighey and Macallister, 2012; Russell et al., 2014; Hausenloy and Yellon, 2016). Remote 
preconditioning via activation of peripheral nociceptors by non-ischemic stimuli (traumatic 
wound injury) were also studied (Jones et al., 2009). TRPV1 activation is involved in remote 
postconditioning (Gao et al., 2015) and rutacarpine, a useful herbal drug in the treatment of 
hypertension and angina pectoris has been shown to exert its cardioprotective effect, at least 
in part through an action on capsaicin-sensitive nerves (Hu et al., 2003). CGRP is also 
involved in human cardiac pathologies: an early increase in plasma CGRP level has been 
demonstrated in patients with myocardial infarction (Lechleitner et al., 1992) and 
administration of this peptide has been shown to delay the onset of myocardial ischemia upon 
physical exercise in patients with stable angina pectoris (Uren et al., 1993). In conclusion 
chemosensitive cardiac nerves play a crucial role in the adaptive/protective responses of the 
heart. The importance of cardiac peptidergic sensory nerves in cardiac adaptation to ischemic 
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stress is well established, but little is known about their possible protective role in drug-
induced cardiotoxicity. 
 
Anthracycline-induced cardiotoxicity, and neurotoxicity  
Anthracyclines have been introduced into clinical oncology in the past century (Di 
Marco et al., 1969). Despite serious side effects, anthracyclines have soon become 
indispensable in the treatment of many malignancies (Davis and Davis, 1979). Hence, 
anthracycline-type cytostatic agents are still widely used in both adult and pediatric oncology. 
Adriamycin exerts its antimitotic effect by intercalating DNA base pairs leading to breaks in 
the helical strands (Pigram et al., 1972; Buja et al., 1974) and by inhibiting DNA-dependent 
enzymes. Adriamycin was shown to inhibit protein synthesis in cell-free systems but not in 
intact cells (Momparler et al., 1976). Studies on anthracycline distribution within tissues and 
cell compartments are based on its natural fluorescence (Egorin et al., 1974; Danesi et al., 
1974; Hindenburg et al., 1989) or on the use of immunosilver staining techniques 
(Henneberry and Aherne, 1992). After intravenous administration of the drug, the access to 
the cells depends on the vascularization of the tissue, the strength of the endothelial barrier 
systems and the binding of the drug to membrane sites (Tritton and Yee, 1982). The 
unchanged form of the drug is transported via passive diffusion across the cell membranes 
(Mayer et al., 1986; Frézard and Garnier-Suillerot, 1991). Adriamycin is a weak base 
(pK=8.3), and the cellular uptake is driven by the pH gradient and the concentration gradient. 
Binding of the drug to the DNA (Chaires et al., 1985;Capranico et al., 1990), to intracellular 
membranes (de Wolf et al., 1993), and its accumulation in acidic organelles (Willingham et 
al., 1986) can play a role in maintaining the concentration gradient. The actual intracellular 
concentration of adriamycin is the result of a dynamic equilibrium of influx and efflux 
processes. Therefore the expression pattern of efflux transporters such as ATP-binding 
cassette proteins (ABC) seems to be an essential factor in the cellular vulnerability for 
anthracyclines. Overexpression of the most studied ABC transporter, the P-glycoprotein, was 
shown to be associated with an acquired resistance to the cytostatic agent (Couture et al., 
2006). ABC transporters, on the one hand, can protect the organism from the toxic effect of 
the xenobiotic but, on the other hand, their overexpression in tumor cells can limit the 
therapeutic effect.   
The cardiotoxic effects are the most serious side effects of anthracyclines which are 
difficult to predict and even more difficult to manage. Congestive dilatative cardiomyopathy 
is the most serious manifestation of adriamycin cardiotoxicity which develops in 1.7% to 
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6.8% of the patients; the prevalence is highly dependent on the total dose administered 
(Minow and Benjamin, 1975; Lefrak et al., 1975; Praga et al., 1979; Suzuki et al., 1979). 
Potentially fatal cardiotoxicity has a rising probability at a cumulative dose of >550 mg/m2 
(Lenaz and Page, 1976). Children appear to be at greater risk at any given dose (Gilladoga et 
al., 1975). The outstanding clinical feature of its cardiotoxic effect is the insidious onset, 
followed by a rapid progressive biventricular failure and death. The lack of presently 
available effective treatment of established cardiomyopathy lays special emphasis on the 
development of possible preventive treatments. Therefore, extensive research has been and is 
being done to understand the pathomechanism of adriamycin cardiotoxicity. Experimental 
cardiomyopathy induced by adriamycin has been studied in rats (Schwarz et al., 1998a), dogs 
(Van Vleet et al., 1980), rabbits and mice (Lambertenghi-Deliliers et al., 1976). 
The special ability to bind to the phospholipid cardiolipin and to form a nearly-
irreversible complex with this mitochondrial inner membrane protein is considered as the first 
step of adriamycin cardiotoxicity in several studies (Rahman et al., 1985; de Wolf, 1991). 
Accumulation of adriamycin in the heart also depends on the rate of its transport out of the 
cells (Couture et al., 2006). Several members of the P-glycoprotein group of ABC 
transporters, named multidrug resistance-associated proteins (MRP) were found in high levels 
in the heart of many species including man (Flens et al., 1996; Meissner et al., 2004). 
Polymorphism in ABC transporter genes  have been shown to modulate drug disposition, and 
might  be responsible for  interindividual variability in both the therapeutic and the toxic 
effect of the drug, but its exact impact on cardiac drug levels remains to be elucidated. It is 
probable that some drugs, for example verapamil or cyclosporine A, that are clinically proved 
to enhance the cardiotoxic effect of anthracyclines, act by inhibiting P-glycoprotein or other 
ABC transporters; paclitaxel might also have a similar effect (Couture et al., 2006). Because 
of the heart’s unique vulnerability to oxidative stress, adriamycin-induced free radical 
production and subsequent lipid peroxidation (Bachur et al., 1977) has been extensively 
studied, and the participation of several mitochondrial enzymes (Davies and Doroshow, 1986) 
has been disclosed. Increased endothelial nitric oxide synthesis and apoptosis (Kalivendi et 
al., 2001; Bruynzeel et al., 2007) also contribute to the cardiac injury. The cardiotoxic effect 
of adriamycin is likewise related to impairment of DNA replication (Singal et al., 1997), 
disturbances of calcium homeostasis (Olson-RD and Mushlin, 1990), and altered iron 
homeostasis (Xu et al., 2005). Adriamycin affects cardiac-specific gene expression as well. 
Cardiac adriamycin-responsive protein (CARP) appears to function as a negative regulator of 
cardiac-specific gene expression and its overexpression in cardiomyocytes suppresses cardiac 
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troponin C and atrial natriuretic factor transcription (Umlauf and Horky, 2002), but the 
downregulation of α-actin, myosin light- and heavy chains and sarcoplasmic reticulum ATP-
ase has also been suggested to play a role in adriamycin cardiotoxicity. Similarly, changes in 
the high energy phosphate pools, disturbances in the endothelin, cannabinoid, and 
neuroregulin signaling pathways, ceramide accumulation and extracellular matrix remodeling 
can also contribute to the pathomechanism (for a review see Octavia et al., 2012).   
Besides the chronic cardiotoxic effect, acute cardiotoxicity of adriamycin also occurs, 
presenting mainly with arrhythmias and myocardial apoptosis (Arola et al., 2000). In humans 
the incidence of acute cardiotoxicity is relatively high (~11%), and occurs during and within 
2-3 days of the administration of the drug, and the manifestations are usually chest pain due 
myo-pericarditis, sinus tachycardia, paroxysmal nonsustained supraventricular tachycardia, 
and premature atrial and ventricular beats. The electrocardiogram may show nonspecific ST-T 
changes, decreased QRS amplitude and left axis deviation. Acute left ventricular failure is 
rare, and the acute effects of the drug are usually reversible (reviewed by Chatterjee et al., 
2010).  
Anthracycline cardiotoxicity is a multifactorial process, many mechanisms of which 
are different from those implicated in the therapeutic effect of the drug. Jeon et al concluded 
that damage to cardiac adrenergic innervation might also contribute to the pathomechanism of 
adriamycin-induced cardiomyopathy, but little is known about the possible role of sensory 
nerves in the mechanism of anthracycline cardiotoxicity (Jeon et al., 2000).  
Human histopathologic effects of the drug have been studied at autopsy (Suzuki et al., 
1979) and in endo-myocardial biopsy specimens (Billingham et al., 1978). The lesions are 
disseminated but are yet focal: vacuolar degeneration due to distension and swelling of the 
sarcoplasmic reticulum, and later myofibrillar loss can be seen. „Adria Cell” is a term used 
for cardiomyocytes with myofibrillar loss, cytoplasmic vacuolization and central clumping of 
the nuclear chromatin seen by electron microscopy in adriamycin-treated patients. Lesions 
progress to death of the myocyte, at which point the mitochondria degenerate with swelling 
and cristolysis and finally dead myocytes are replaced by fibrotic tissue. In many animal 
models similar histopathologic changes were observed. Animal studies pointed to the fact that 
a number of morphological signs appear before the onset of congestive heart failure (for a 
review see (Saltier and McGuire, 1983).  
Similar changes were recognized in post mortem examination of dorsal root and 
cardiac ganglia of adriamycin- or daunorubicin-treated patients (Smith, 1969). Adriamycin 
does not pass the blood brain barrier in vivo, but has rapid access to cells in the dorsal root 
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ganglia (Bigotte et al., 1982) and exerts a pronounced neurotoxic effect in experimental 
animals. In rats, administration of a single high dose of adriamycin lead to selective sensory 
neuropathy, with characteristic morphological changes and cell death in DRGs (Cho, 1977; 
Eddy, 1983). Cellular degeneration was also present in cultures of DRGs exposed to 
adriamycin (Zagoren et al., 1984). In mice, intramuscular or intraneural injection of the drug 
reaches the CNS via retrograde axonal transport and induces degeneration of motoneurons 
and other types of nerve cells (Bigotte and Olsson, 1983).  
It is difficult to estimate the clinical prevalence of the neurotoxic effect of adriamycin 
because it is often given in combination with other cytostatic agents with known neurotoxic 
propensity. Vinca alkaloids are particularly neurotoxic. Other cytostatic drugs can cause 
peripheral neuropathies, but are less neurotoxic than vincristine (Rosenthal and Kaufman, 
1974). The clinical features of vincristine neuropathy are well documented (Holland et al., 
1973). Other oncolytic drugs associated with peripheral neuropathy include cisplatin, 
suramin, paclitaxel, chlorambucil, altretamine, carboplatin, cytarabine, docetaxel, 
dacarbazine, etoposide, fludarabine, tamoxifen, teniposide, and thioguanine, (for reviews see 
Scripture et al., 2006; Kanbayashi et al., 2010; Grisold et al., 2012). Most drug-induced 
neuropathies affect solely the sensory nerves or are mixed sensorimotor in nature. Usually 
mixed peripheral neuropathies present sensory symptoms prior to progressing to motor 
impairments. Autonomic neuropathy may also develop following the administration of 
anticancer agents.  
 
Aims of the study 
Peptidergic cardiac nerves have been demonstrated to play a significant role in cardiac 
function under pathophysiological and possibly physiological conditions. However, the 
participation of cardiac sensory nerves in the pathomechanism of anthracycline-induced toxic 
cardiomyopathy has not been considered, yet. With regard to the pivotal significance of 
chemosensitive afferent nerves expressing TRPV1 and CGRP in myocardial protective 
mechanisms, the present experiments were conducted in an attempt to reveal a possible role 
of these particular nociceptive sensory nerves in the development of adriamycin-induced 
experimental cardiomyopathy in the rat. 
Chemosensitive afferent nerves innervating different organs and tissues share many 
common traits in terms of their morphology, neurochemistry and function. The cutaneous 
chemosensitive afferent nerves are the best-characterized class of this particular population of 
sensory nerves (Roosterman et al., 2006; Jancsó et al., 2009a). Through application of a 
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treatment paradigm previously shown to produce congestive cardiomyopathy in the rat, an 
additional aim of the present work was therefore an explanation of the neurotoxic effects of 
adriamycin on chemosensitive afferent nerves through studies of cutaneous neurogenic 
sensory vasodilatation, neurogenic plasma extravasation, inflammatory hyperalgesia and 
innervation, and measurement of CGRP release from sensory nerves. 
 
The specific aims of this thesis were as follows: 
 
1) The exploration of the possible contribution of cardiac chemosensitive peptidergic nerves 
to protective mechanisms against adriamycin-induced cardiotoxicity by comparing the 
severity and dynamics of progression of cardiac failure/damage in intact and 
chemodenervated rats. 
 
2) The evaluation of the neurotoxic effects of adriamycin on the local regulatory, „sensory 
efferent” functions of cutaneous chemosensitive afferent nerves. The assessment of the dose- 
and time-dependent effects of adriamycin on cutaneous neurogenic vasodilatation, plasma 
extravasation, inflammatory hyperalgesia and the axonal release of CGRP.  
 
3) The quantitative analysis of the morphological effects of adriamycin on cutaneous 
innervation and skin structure. 
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MATERIALS AND METHODS 
 
This study conformed fully to the Principles of laboratory animal care  (NIH 
publication No. 85-23, revised 1985) and was approved in advance by the Animal Research 
Ethics Committee of the University of Szeged. 
 
Adriamycin treatment  
Adult male Wistar rats weighing 250 ± 30 g at the start of the experiments were used 
in the study. Adriamycin (doxorubicin) treatment was induced according to the treatment 
schedule introduced by Tong et al (Tong et al., 1991). The animals received a cumulative 
dose of 15 mg/kg of adriamycin (Pharmacia Italia, Milan, Italy) by systemic injection of 2.5 
mg/kg of the drug three times a week for 2 weeks. The control rats received equivalent 
amounts of the vehicle (saline). Tests other than echocardiography were made 2-7 days after 
the cessation of the adriamycin treatment. 
 
Selective sensory chemodenervation induced by systemic capsaicin treatment 
A group of rats (n=23) was pretreated with capsaicin (Fluka, 10, 20 and 100 mg/kg 
subcutaneously injected on 3 consecutive days) or its vehicle (6% ethanol, 8% Tween 80 in 
saline, n=6) under ether anesthesia 2 weeks prior to the induction of adriamycin treatment. 
This capsaicin treatment paradigm has been shown to result in a practically complete 
elimination of CGRP-containing cardiac sensory nerves (Ferdinandy et al., 1997). 
 
Echocardiac assessment of cardiomyopathy 
Cardiac function was assessed by echocardiographic examination before and at regular 
intervals after capsaicin and/or adriamycin treatment. Echocardiography was performed 
essentially as described by Schwarz et al (Schwarz et al., 1998a;  et al., 1998b). The rats were 
anesthetized with ether, the chest was shaved and the animal was placed in the supine 
position. Two-dimensional and M-mode echocardiographic examinations were performed in 
accordance with the criteria of the American Society of Echocardiography, with a Desmin F 
ultrasound scanner (Echo-Son, Poland), using 5 and 7.5 MHz phased-array transducers. The 
investigator who analyzed the echocardiograms was unaware of the modes of treatment that 
the animals had undergone. At all-time points, three measurements were made in each animal, 
and the mean values were calculated and used for statistical evaluation of the data. The left 
ventricle (LV) was examined in the parasternal long-axis view at the level of the mitral valve, 
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or in the parasternal short-axis view at the level of the papillary muscles. The LV diameters 
were measured by means of M-mode echocardiography between the endocardial borders. The 
LV end-diastolic diameter (LVDD) was measured at the longest diameter of the LV. The LV 
end-systolic diameter (LVSD) was measured at the shortest diameter of the LV. The 
fractional shortening (FS) was calculated by using the LV diameters (LVDD–LVSD)/LVDD, 
and was expressed as a percentage. The left atrial diameter (LAD) and aortic diameter (AOD) 
were measured by M-mode echocardiography at the level of the longest LAD. Three cardiac 
cycles were measured, and the mean values were calculated and utilized for the evaluation of 
the data. The ratio LAD/AOD was calculated. Values are given as means ± SEM. Pericardial 
and pleural effusion was detected by the examination of fluid accumulation between the 
layers of the epicardium and the pericardium and between the layers of the visceral and 
parietal pleurae, respectively, with two-dimensional and M-mode echocardiography. Ascites 
was visualized from the subcostal four-chamber or short-axis view below the diaphragm by 
means of two-dimensional ultrasonography.  
 
Immunohistochemical examination of cardiac tissues 
For cardiac immunohistochemical studies additional groups of rats treated with 
adriamycin (n=3) and capsaicin plus adriamycin (n=3) were perfused via the left heart 
ventricle with Zamboni s fixative 2 weeks after the completion of the administration of 
adriamycin. The hearts were removed and after a post-fixation period of 3 h they were placed 
in a buffer solution and stored at 4°C until sectioning. Transverse sections through the 
ventricles were cut at a thickness of 20 µm and were processed for immunohistochemical 
staining with the indirect immunofluorescence technique by using rabbit polyclonal antisera 
raised against protein gene product 9.5 (PGP 9.5, 1:1000; Ultraclone, Cambridge, UK) and 
CGRP (1:500, Sigma Chemicals, St Louis, MO, USA). Goat anti-rabbit IgG labeled with Cy3 
(carboxymethylindocyanin, 1:500, Jackson ImmunoResearch Laboratories, West Grove, PA, 
USA) was used as a secondary antibody. The specimens were viewed under a Leitz DMLB 
fluorescence microscope equipped with an appropriate filter combination and photographed 
with a digital camera (Nikon Coolpix 950). 
 
Measurement of chemically induced neurogenic cutaneous vasodilatation 
Animals were anesthetized with chloral hydrate (400 mg/kg, i.p., Reanal, Budapest, 
Hungary). Body temperature was maintained at 37.2 ± 0.5 oC with a heating pad. A small 
silicone chamber (5 mm in diameter) was mounted on the middle region of the dorsal skin of 
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the hind paw to avoid the lateral spreading of the applied solutions. Cutaneous blood flow 
(CuBF) was monitored with a Laser Doppler Blood Flow (LDF) Monitor (type MBF3, Moor 
Instruments Ltd, Axminster, Devon, UK) by positioning the probe over the surface of the skin 
in the center of the chamber.  After a stable LDF signal was attained, 20 µl of mustard oil 
(0.2%, allyl-isothiocyanate, Merck, Darmstadt, Germany) was applied onto the skin through a 
polyethylene cannula built into the wall of the chamber and the CuBF was recorded for 15-20 
min. This procedure was repeated 45 min later with a higher concentration of mustard oil 
(1%). We also studied the vasodilatory effect of capsaicin (1%, Fluka, Buchs, Switzerland) in 
a similar set of experiments. Relative increases in CuBF were calculated by comparing the 3-
min pre-drug mean CuBF with the mean of consecutive 1-min LDF signal values recorded 
after the application of test agents. The effects of pretreatments with the specific TRPA1 and 
TRPV1 antagonists, HC-030031 (Tocris, Bristol, UK) and capsazepine (Sigma-Aldrich 
GmbH, Germany), respectively, were also tested. Capsaicin was dissolved in ethanol. Stock 
solutions of HC-030031 (100 mM) and capsazepine (10 mM) were prepared with dimethyl 
sulfoxide and ethanol, respectively. Mustard oil was diluted with ethanol. 
 
Measurement of chemically induced cutaneous plasma protein extravasation 
Neurogenic plasma extravasation was evoked and quantified as described previously. 
Briefly, animals were anesthetized with chloral hydrate and injected intravenously with Evans 
blue dye (50 mg/kg, 1% in saline). Ten minutes later, the dorsal skin of the hind paws was 
painted with a solution of 5% mustard oil, 1% capsaicin or their solvent (liquid paraffin and 
ethanol, respectively). The effects of pretreatments with the specific TRPA1 and TRPV1 
antagonists, HC-030031 and capsazepine, respectively, were also tested. After 20 min, the 
animals were perfused transcardially with saline, and samples of the dorsal paw skin were 
removed, weighed and placed into formamide to extract the dye for quantitative photometric 
determination (Jancsó et al., 1977). Tissue Evans blue contents were expressed in µg dye/g 
tissue as mean ± S.D. Plasma extravasation induced by histamine, bradykinin and substance P 
was also measured with the Evans blue technique following the intracutaneous injections of 
these vasoactive agents into the abdominal region. The doses of these agents were chosen to 
produce dye leakage responses of similar magnitude. Skin sites injected with the solvent 
(artificial interstitial fluid, 0.1 ml) served as controls. Twenty min after the injections, rats 
were sacrificed by decapitation and abdominal skin samples of standardized size were 
removed and their dye contents were measured as described above. 
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Measurement of CGRP release in vitro 
The animals were anesthetized with chloral hydrate, sacrificed by decapitation, and the 
sciatic nerves were removed. The epineurium was carefully removed from the nerves under 
microscopic control and the samples were washed with synthetic interstitial fluid (SIF, 
containing in mM: 107.8 NaCl, 26.2 NaHCO3, 9.64 Na-gluconate, 7.6 sucrose, 5.55 glucose, 
3.48 KCl, 1.67 NaH2PO4, 1.53 CaCl2 and 0.69 MgSO4) gassed with 95% O2 and 5% CO2 to a 
pH of 7.4 at room temperature for 30 min. Thereafter, the SIF was replaced with 400 μl of the 
release buffer consisting of SIF supplemented with 0.1% bovine serum albumin and 16 μM 
thiorphan (Price et al., 2005). After an incubation period of 10 min to measure the basal 
CGRP release, the buffer was replaced either with a release buffer containing 10 μM 
capsaicin or with a modified release buffer containing 60 mM KCl. The tissue samples were 
then further incubated for 10 min to determine the capsaicin- and the depolarization-induced 
CGRP release. The effect of capsazepine, a specific TRPV1 antagonist, on the capsaicin-
induced CGRP release was also studied. Samples were collected at the end of each incubation 
period into silicone-coated Eppendorf cups, frozen and stored at -70 °C until the 
determination of their CGRP content. The wet weights of the nerves were also measured. The 
CGRP concentrations of the samples were determined with an enzyme-linked immunoassay 
kit (ELISA, Bertin Pharma, Montigny-le-Bretonneux, France) according to the protocol 
provided by the manufacturer. The absorbances of the samples were measured 
photometrically with a microplate reader (DY-NEX MRX, Dynex Technologies, Chantilly, 
USA), and the CGRP contents were calculated and corrected for the tissue weights. The 
results (mean ± S.D.) are expressed as percentages of the basal CGRP release.  
 
Carrageenan-induced thermal and mechanical hyperalgesia  
The nociceptive paw withdrawal response to radiant heat stimulation was studied by 
the Hargreaves method (Hargreaves et al., 1988). The animals were placed on a glass surface 
in a transparent plastic cage and were allowed to adapt to their environment for 15 min before 
testing. The heat stimulus was directed onto the plantar surface of the hind paw. The 
withdrawal latency was measured three times on both hind paws of each rat, the means of the 
measured data serving as baseline for the left and right hind paws. The apparatus was 
calibrated to give a withdrawal latency of about 10 s in control animals. To prevent tissue 
damage, a cutoff-time of 20 s was chosen. For the assessment of carrageenan-induced thermal 
hyperalgesia, rats received an intraplantar injection of carrageenan (3 mg in 0.1 ml saline, 
Sigma-Aldrich GmbH, Steinheim, Germany) into the right hind paw. The paw withdrawal 
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latencies were measured 3 h after the carrageenan injection, and the data were expressed as 
percentage changes (mean ± S.D.) from the control values.  
Paw withdrawal thresholds for mechanical stimulation were measured in both hind 
paws with an automated apparatus suitable for the application of reproducible mechanical 
stimuli (Dynamic plantar aesthesiometer, Ugo Basile, Gemonio, Varese, Italy). Rats were 
placed on a metal mesh table and allowed to adapt to their new compartments. With the help 
of an adjustable angled mirror, the mechanical stimulus was directed to the plantar surface of 
the hind paw from below the floor. When the unit was started, a steel rod was pushed against 
the plantar surface of the hind paw with increasing force of 0 to 50 g over a 20-s period. As 
the animal withdrew its hind paw or an applied force of 50 g was reached, the stimulation was 
stopped and the force at which the response occurred was recorded. This procedure was 
repeated three times and the withdrawal responses were averaged. Mechanical hyperalgesia 
was assessed after an intraplantar injection of carrageenan as described above. The latency of 
withdrawal responses were measured 3 h after carrageenan. The data were expressed as 
percentage changes (mean ± S.D.) from the control. 
 
Kinematic analysis of hindlimb locomotor function 
Experimental setup 
For the kinematic analysis of the locomotion of intact and treated animals a 
transparent plexiglass runway (100 cm [L] x 15 cm [W]) with a tilted mirror fixed under the 
floor plate was used. Another mirror system was fixed behind the runway in order to observe 
the movements of the contralateral limb, too. A square grid pattern with 1 cm intervals was 
scratched into the front panel for calibration purposes. The rats were trained prior to the 
measurements to walk from one end of the runway to the other reaching a shelter. The hair of 
the animals was shaved off from the hindlimbs and the skin was marked with permanent 
black ink above the major joints. The locomotor pattern of the rats was recorded with high 
resolution and high speed digital cameras. The analysis of locomotor function was performed 
on basis of the observations published earlier by other laboratories (Ribotta et al., 2000;Fey et 
al., 2010) and of our own observations on animals that had suffered from an ongoing 
motoneuron degeneration and/or loss (Nógrádi and Vrbová, 2001; Nógrádi et al., 2007; Pájer 
et al., 2014)). A methodological manuscript detailing the description of the above set up and 
analysis is currently being prepared for publication.  
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Locomotor data analysis  
We recorded 3 runs of each animal in every session and examined 5 steps complying 
two criteria: one similar step was required before and after the measured step and the head of 
the animal had to point to the direction of walk. The appropriate video sequences were 
divided into single frames using the VirtualDub software and the selected frames where the 
animals were in a defined phase of movement were analyzed by using the ImageJ software 
(NIH, USA). The following parameters were determined and used in the analysis of 
locomotion in this study. Lateral view parameters were defined as follows. Step length: the 
length of the step cycle measured between the first moments of the consequent stance phases 
expressed in cm; tarsus off angle: the angle enclosed by the tarsus and the floor plate at the 
last moment of the stance phase expressed in degrees; ankleflexion: the angle enclosed by the 
tarsus and the tibia at the first moment of the stance phase expressed in degrees; knee flexion: 
the angle enclosed by the tibia and the femur at the first moment of the stance phase 
expressed in degrees; lateral placing: the angle enclosed by the tarsus and the longitudinal 
axis of the animal. We measured this parameter at the first moment of the stance phase 
expressed in degrees. Ankle lifting: the highest point reached by the ankle joint during the 
swing phase compared to its lowest position on the ground (in mm); knee lifting: the highest 
point reached by the knee joint during the swing phase compared to its lowest position on the 
ground (in mm). Rear-view parameters were defined as follows. Metatarsus-surface angle: the 
angle enclosed by the metatarsus and the surface (expressed in degrees) at the first moment of 
the swing phase when the foot has just left the ground; spreading of toes: the angle opening 
between the 2nd and the 4th toes is determined in degrees at the first moment of the swing 
phase when the foot has just left the ground.  
 
Demonstration of cutaneous innervation by immunohistochemistry and quantitative 
morphometry 
For immunohistochemical studies, adriamycin- or vehicle-treated rats were perfused 
via the left heart ventricle with 4% buffered formaldehyde solution 2-7 days after the 
completion of treatment. The plantar skin of the hind paws was removed and, after a post-
fixation period of 3 h, was placed into a buffer solution and stored at 4 °C until sectioning. 
Skin samples were taken from the mid-plantar region of the paw and transverse sections were 
cut at a thickness of 25 μm and processed for immunohistochemical staining with the indirect 
immunofluorescence technique by using antisera raised against the TRPV1 receptor (rabbit 
polyclonal, 1:1000-1:1500, Alomone Laboratories, Jerusalem, Israel) and β-tubulin  (mouse 
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monoclonal, 1:1000, Sigma-Aldrich GmbH, Steinheim, Germany). Donkey anti-rabbit and 
anti-mouse IgGs labeled with Cy3, DL-488 (1:500, Jackson Immunoresearch Laboratories, 
West Grove, PA, USA) were used as secondary antibodies. Control procedures for 
immunolabeling were performed by replacing the primary antisera by normal donkey serum. 
To test the specificity of the TRPV1 antibody we have also performed a preadsorption test by 
applying a blocking peptide (supplied by the manufacturer of the TRPV1 antibody) 
representing the immunogenic fragment of TRPV1 against which the antibody was generated. 
No staining was observed in either case. Slides were covered with ProLong Gold Antifade 
Mountant with or without DAPI (Invitrogen, ThermoFisher Scientific, Budapest, Hungary).  
The specimens were viewed under a Zeiss confocal fluorescence microscope. Z-stack 
image series were collected from sections of plantar skin samples obtained from control and 
adriamycin-treated rats. The density of epidermal axons was estimated with the vertical 
projection method. This design-based stereological approach allows an unbiased estimation of 
the length density of linear structures in a given volume (Gokhale, 1990). Systemic random 
projection images of the epidermis were obtained from 25-µm-thick cryostat sections of the 
plantar skin of the hind paw. By using the filter grid cycloid arc plug-in of the Image-J image 
analysis software (Image Processing and Analysis in Java, National Institutes of Health, 
USA), a counting template containing cycloid curves was defined and superimposed onto the 
images. The major axis of the cycloid curves was aligned perpendicular to the skin surface. 
The total length of the cycloid curves and the number of counting grid points were optimized 
by performing pilot experiments on control skin sections. The factor l/p (length of test line per 
grid point) was set at 12.046 µm. Intersections of the epidermal nerve fibers with the cycloid 
arcs, and the number of grid points coinciding with the area representing the cross-section of 
the epidermal layer were determined on each image. The length density (Lv) of the 
intraepidermal nerve fibers was determined via the equation Lv = 2 x li/d x Pi x (l/p), where li 
is the number of cycloid intersections, d is the thickness of the section and Pi is the number of 
grid points hitting the cross section area of the epidermis. 
The epidermal thickness was also measured along a line perpendicular to the skin 
surface with the aid of Image-J software in sections prepared for immunohistochemistry and 
covered with a mounting medium containing DAPI to visualize cell nuclei. Epidermal 
thickness was calculated as the average of 6 measurements on each sample from control and 
adriamycin-treated rats. 
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Statistics 
Statistical evaluation of the experimental cardiomyopathic data was performed with 
ANOVA, followed by the Bonferroni test. A probability level p<0.05 was regarded as a 
statistically significant difference between groups. The values of the survival proportions ± 
SEM were calculated. To compare the survival experience of the animals of the two groups, 
the non-parametric log rank test was applied. Since more than one event was registered at 
certain times of observations, we calculated the X
2
 value by a formula described by (Altman, 
1991). Pairwise comparisons between the survival proportions observed at the completion of 
adriamycin treatment and at the end of the 2nd, 3rd, and 4th weeks of the post-treatment 
period were performed using Fisher s exact test and the p values were corrected by 
Bonferroni s method. For the statistical comparisons of the mustard oil-induced vasodilatory 
responses two-way ANOVA was performed with pairwise comparisons based on Estimated 
Marginal Means using the Bonferroni post-hoc analysis, whereas one-way ANOVA was used 
for comparisons of the capsaicin-induced blood flow changes. One-way ANOVA was used to 
compare Evans blue contents of skin samples. The Student t-test (unpaired) was applied for 
the statistical analyses of the data concerning the paw withdrawal responses, the in vitro 
CGRP release and the immunohistochemical experiments. In all groups normality was proved 
by the Shapiro-Wilk test and homogeneity of variances was confirmed by Levene’s test in 
advance of performing two-way ANOVA. One-way ANOVA was applied to analyze the 
results of the hindlimb locomotor parameters. In all comparisons, a p value of <0.05 was 
accepted as a significant difference. 
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RESULTS 
 
Anthracycline cardiotoxicity assessed by echocardiography, effect of systemic capsaicin 
pretreatment 
The cardiac parameters measured by echocardiographic examination in control, 
capsaicin-, adriamycin-, and capsaicin plus adriamycin-treated rats are presented in Table 1. 
The echocardiograms in Fig. 1 illustrate the techniques used to measure the 
echocardiographic parameters involving AOD, LAD, LVSD, and LVDD. Sequential 
echocardiographic examination of the control animals demonstrated little change in the 
cardiac parameters during the period of the study. Since there was no significant difference 
between the parameters of the two control groups, treated with the vehicles for capsaicin and 
adriamycin, respectively. For subsequent statistical evaluation, they were lumped together as 
a single control group. None of the rats in this control group died or developed pathologies 
associated with cardiac failure during the period of the study. Fractional shortening at the 
beginning of the study was 25.3±1.5% and did not exhibit any significant change throughout 
the entire study period. Examination of the rats treated with capsaicin revealed that there was 
no significant change in FS as compared with the initial baseline value or that for the control 
group. During the period of the study, the follow-up examinations indicated that there was no 
change in FS of rats treated only with capsaicin. 
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Fig. 1 (a) M-mode echocardiogram of the aorta (Ao) 
and the left atrium (LA) illustrating the technique used 
to measure the aortic (AOD) and left atrial dimensions 
(LAD). A normal ratio of LAD and AOD is measured 
in the parasternal long axis view in a control rat. (b) M-
mode echocardiogram of the left ventricle (LV) in the 
parasternal long axis view illustrating the method used 
to measure the ventricular dimensions in a control rat. 
The left ventricular end-diastolic diameter (LVDD) and 
the left ventricular end-systolic diameter (LVSD) 
measurements are done from the leading edge at the 
end of the diastole and at the end of the systole. Normal 
contractility of the left ventricle can be seen. (c) An 
enlarged LV can be seen by M-mode echocardiography 
in the parasternal long axis view in a rat treated with 
capsaicin plus adriamycin. The contractility of the left 
ventricle is markedly decreased 
 
 
 
 
 
 
 
 
In rats treated only with adriamycin, echocardiographic measurements of the LV dimensions 
3 and 4 weeks after the completion of drug administration demonstrated significant increases 
in the LVSD. LVDD did not change significantly in these animals. The ratio LAD/AOD was 
already significantly increased 1 week after the completion of the treatment (Fig. 2a, Table I). 
In the rats treated with capsaicin plus adriamycin, LVSD was increased significantly already 
by the end of the 1st week after the completion of adriamycin administration. By the end of 
the 3rd week after the completion of adriamycin administration, both LVDD and LVSD were 
increased significantly. The ratio LAD/AOD was already significantly increased 1 week after 
the completion of adriamycin treatment (Fig. 1, Table 1).In the rats treated with adriamycin, 
the echocardiographic examinations revealed a progressive reduction in FS, indicating a 
decrease in cardiac contractility (Fig. 1c), from the 2nd week onwards after the completion of 
the administration of the drug, but this became statistically significant only in the 4th week 
post-treatment (Fig. 2b, Table I). In contrast, a marked and significant reduction in FS was 
already observed 1 week after the completion of adriamycin treatment in the rats pretreated 
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with capsaicin. Statistical analysis of the data showed that, with the exception of the 4th week 
post-treatment, the FS in the capsaicin plus adriamycin-treated rats was markedly lower than 
that in the rats treated only with adriamycin (Fig. 2b, Table I). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 (a) Ratio of LAD and AOD and (b) fractional shortening of the left ventricle in control (open bars), 
capsaicin-treated (cross-hatched bars), adriamycin-treated (horizontally hatched bars), and capsaicin plus 
adriamycin-treated (filled bars) groups of rats before (Start), and 3 days (End) and 1–4 weeks after the 
completion of the adriamycin treatment. The asterisk and the hash sign denote statistically significant differences 
(p<0.05) between selected groups or in comparison with the initial control value respectively. Each column 
depicts the mean of values obtained from at least five rats. 
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Table I Cardiac parameters measured by echocardiographic examination in control, capsaicin-, adriamycin- and capsaicin plus adriamycin-treated rats.  
AOD aortic diameter, LAD left atrial diameter, LVVD left ventricular end diastolic diameter, LVSD left ventricular end systolic diameter, FS fractional shortening 
Values are expressed in mm as mean  SEM obtained from at least 5 animals. § Time after completion of the treatment with adriamycin.* Significantly different from the 
initial baseline value.# Significantly different from the values of the corresponding control group. 
       
     Aortic Diameter (AOD)  Left Atrial Diameter (LAD)  LAD/AOD  
       
Treatme
nt 
period 
 Control Capsaicin Adriamycin Capsaicin 
 
+Adriamyci
n 
 Control Capsaicin Adriamycin Capsaicin 
+Adriamyci
n 
 Control Capsaicin Adriamycin Capsaicin 
+Adriamyci
n 
Start 
 
3.42±0.12 3.06±0.22 3.39±0.12 3.29±0.09  3.77±0.26 3.35±0.26 3.59±0.15 3.56±0.12  1.10±0.04 1.10±0.06 1.06±0.05 1.08±0.04 
End 
 
3.37±0.09 3.37±0.24 3.36±0.13 3.03±0.14  3.63±0.12 3.56±0.26 4.33±0.16* 3.59±0.17  1.08±0.02 1.07±0.05 1.27±0.07 1.20±0.05 
1 week§ 
 
3.35±0.10 3.45±0.15 3.47±0.13 3.00±0.17  3.52±0.07 3.80±0.13 4.42±0.16*# 4.10±0.22*#  1.05±0.01 1.10±0.06 1.28±0.05*# 1.37±0.07*# 
2 
weeks§ 
 
3.60±0.16 3.28±0.16 3.28±0.14 3.28±0.12  4.11±0.28 3.41±0.28 4.44±0.17*# 5.54±0.25*#  1.14±0.03 1.25±0.07 1.37±0.05*# 1.69±0.05*# 
3 
weeks§ 
 
3.52±0.16 3.20±0.11 3.27±0.16 3.36±0.14  3.97±0.26 3.64±0.23 5.03±0.22*# 5.31±0.27*#  1.13±0.02 1.14±0.06 1.53±0.06*# 1.58±0.05*# 
4 
weeks§ 
 
3.62±0.12 3.48±0.19 3.15±0.17 3.24±0.16  3.87±0.14 3.79±0.36 4.69±0.22*# 5.41±0.31*#  1.07±0.02 1.09±0.05 1.49±0.07*# 1.67±0.06*# 
                
       
  Left Ventricular End Diastolic Diameter (LVDD)  Left Ventricular End Systolic Diameter (LVSD)  Fractional Shortening (FS) 
       
Treatme
nt 
period 
 Control Capsaicin Adriamycin Capsaicin 
+Adriamyci
n 
 Control Capsaicin Adriamycin Capsaicin 
+Adriamyci
n 
 Control Capsaicin Adriamycin Capsaicin 
+Adriamycin 
Start 
 
5.460.19 5.200.26 5.330.30 5.460.17 
 
4.110.14 3.940.24 4.060.17 4.110.14 
 
0.250.01 0.240.02 0.240.02 0.250.01 
End 
 
5.700.11 5.310.34 5.520.21 5.680.24 
 
4.310.23 4.040.30 4.230.19 4.230.21 
 
0.240.05 0.240.02 0.230.02 0.250.02 
1 week§ 
 
5.650.14 5.530.18 5.400.17 6.010.30 
 
4.330.13 4.190.17 4.000.16 4.950.27*# 
 
0.230.02 0.240.02 0.260.02 0.170.02* 
2 
weeks§ 
 
5.760.11 5.490.22 5.400.32 5.830.22 
 
4.410.12 4.210.26 4.280.27  5.030.19*# 
 
0.230.02 0.230.03 0.220.02 0.140.02*# 
3 
weeks§ 
 
5.830.18 5.580.57 5.650.29 6.450.24*# 
 
4.330.07 4.180.43 4.690.18* 5.520.21*# 
 
0.260.04 0.250.03 0.170.02 0.140.02*# 
4 
weeks§ 
 
5.800.14 5.810.44 5.400.51 6.680.28*# 
 
4.450.12 4.310.48 4.640.19* 5.750.24*# 
 
0.230.03 0.260.03 0.140.02*# 0.130.03*# 
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Fig. 3 Demonstration of the large amount of 
pleural effusion (PLE) and ascites in the 
subcostal cross-sectional view of an adriamycin-
treated rat by two-dimensional ultrasound 
examination 
 
 
 
 
 
 
 
 
Fig.4 Cross section of the ventricles of control 
(left) and adriamycin-treated (right) rats shows 
dilation of the both ventricles with thinning of the 
ventricular walls, which are characteristic signs 
of congestive dilatative cardiomyopathy 
 
 
 
 
 
 
 
Echocardiography and ultrasonographic examination of the chest and abdomen revealed the 
accumulation of fluid in the pericardial, pleural, and abdominal cavities in adriamycin-treated 
animals (Fig. 3). The cumulative incidences of pericardial effusion, pleural effusion, and 
ascites by the end of the study period were 8, 3, and 8 of the 15 adriamycin-treated rats, and 
11, 3, and 8 of the 17 capsaicin plus adriamycin-treated rats, respectively. Three weeks after 
cessation of adriamycin treatment macroscopic signs of cardiotoxicity became evident in 
sacrificed animal. The ventricles were dilated and ventricular walls, and the septum became 
visible thinner than that of the control animal. 
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Anthracycline- and/or capsaicin-induced changes in the cardiac innervation: 
immunohistochemistry 
Immunohistochemical studies were performed to reveal possible changes in the 
populations of cardiac nerves which, in turn, may contribute to the aggravation of adriamycin-
induced cardiomyopathy in capsaicin-pretreated rats. In control rats, immunohistochemical 
demonstration of cardiac nerves using an antiserum against protein gene product (PGP) 9.5, a 
panneuronal marker, revealed a dense innervation of both the left and right ventricles (Fig.5a, 
b). CGRP-containing nerves innervating the ventricles were far less numerous (Fig.5e). 
Examination of the distribution of PGP 9.5-positive nerve fibers of the heart ventricles of rats 
treated with adriamycin or capsaicin plus adriamycin 2 weeks after completion of adriamycin 
treatment disclosed an innervation pattern similar to that of the controls (Fig.5c, d). In 
contrast, in rats treated with capsaicin plus adriamycin, but not in rats treated only with 
adriamycin, CGRP-containing nerves could not be detected 2 weeks after cessation of 
adriamycin treatment (Fig.5f).  
 
Fig. 5 a–d Protein gene 
product (PGP) 9.5          
immunoreactive 
and e, f calcitonin gene-
related peptide (CGRP)-
immunoreactive nerve fibers 
in tissue sections obtained 
from the left (a,c,e,f) and 
right (b,d) heart ventricles of 
control (a, b) and capsaicin 
plus adriamycin-treated (c–f) 
rats. The distribution pattern 
of PGP 9.5-positive cardiac 
nerves is apparently similar 
in control and treated rats. 
CGRP-immunopositive 
nerves cannot be detected in 
the capsaicin-pretreated rat. 
The scale bar in f indicates 
50 µm and applies to all 
microphotographs 
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Alterations of chemically-induced vascular reactions  
Effects of adriamycin on neurogenic sensory vasodilatation  
In control rats, applications of mustard oil at concentrations of 0.2% and 1%, and 1% 
capsaicin produced significant increases in the CuBF (Fig. 6a, c, d). Subcutaneous (s.c.) 
injection of HC-030031 (100 µM, 50 µl) 20 min before the epicutaneous application of 
mustard oil significantly inhibited the vasodilatory response. The increase in CuBF evoked by 
mustard oil (1%) amounted to 121.80 ± 24.19%, whereas the increase in CuBF after the prior 
administration of the TRPA1 antagonist, HC030031 amounted to 14.47 ± 10.44% (p<0.01, 
n=6/group). The epicutaneous application of capsaicin (1%) resulted in a marked elevation in 
CuBF, which amounted to 167.23 ± 53.36%. Administration of the specific TRPV1 
antagonist, capsazepine (10 µM, 50 µl, s.c.) 20 min before the epicutaneous application of 
capsaicin resulted in a significant inhibition of the vasodilatory effect which amounted to 
27.94 ± 8.95% (p<0.01, n=6/group). In the adriamycin-treated animals, vasodilatory 
responses were measured 2 days after cessation of the treatment. After the administration of a 
cumulative dose of 7.5 mg/kg adriamycin, the CuBF increases elicited with 1% mustard oil 
and 1% capsaicin were reduced by 51% (p<0.01, n=10) and 64% (p<0.01, n=6), respectively, 
whereas the vasodilatory effect of 0.2% mustard oil was not affected significantly (n.s., 
n=10). However, in animals treated with a cumulative dose of 15 mg/kg adriamycin, the 
increase in CuBF was markedly and significantly reduced in response to both 0.2% and 1% 
mustard oil (Fig. 6c), and to 1% capsaicin (Fig. 6d), amounting to 43%, 29%, and 29%, 
respectively, of the control values (p<0.01, n=6-10/group, Table II). 
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Table II Effect of adriamycin pretreatment on chemically-evoked cutaneous sensory 
neurogenic vasodilatation 
 
 
 
 
 
 
 
 
 
Cutaneous blood flow was measured with a laser Doppler flow probe positioned over the dorsal skin of the 
hindpaw. Test agents were applied as described in the text. Percentage changes in blood flow are expressed as 
mean ± S.D.  * Significantly different from the control (p < 0.05, n = 6-10/group). 
 
Effects of adriamycin on neurogenic plasma protein extravasation 
Neurogenic plasma protein extravasation was studied with the quantitative Evans blue 
technique following the epicutaneous application of mustard oil or capsaicin. In control rats, 
both mustard oil (5%) and capsaicin (1%) produced marked plasma protein extravasation, 
with In control rats, epicutaneous application of mustard oil at a concentration of 5%, skin 
Evans blue dye content amounted to 180 ± 68 µg/g, which was markedly and significantly 
reduced to 32.67 ± 17.98 µg/g by the prior s.c. administration of the specific TRPA1 
antagonist HC030031 (p<0.01, n=6/group). Similarly, the specific TRPV1 antagonist 
capsazepine almost completely abolished the vascular permeability increasing effect of 1% 
capsaicin; the Evans blue dye content of the skin amounted to 205.50 ± 60.90 µg/g after the 
application of 1% capsaicin, which was reduced to 32.73 ± 19.75  µg/g by the prior 
administration of capsazepine (p<0.01, n=6/group). Following the administration of a 
cumulative dose of 7.5 mg/kg adriamycin, the mustard oil-induced increase in tissue Evans 
blue content was markedly reduced (72.85 ± 20.84 µg/g, p<0.01, n=8), and after a cumulative 
dose of 15 mg/kg, the low Evans blue dye content of the skin (24.95 ± 10.84 µg/g) indicated 
an almost complete abolition of the neurogenic inflammatory response (p<0.01, n=8; Fig. 6e). 
Similarly, after the administration of adriamycin at cumulative doses of 7.5 and 15 mg/kg, 
 
 
 
Mustard oil   
(0.2%) 
 
 
Mustard oil     
(1%) 
 
Capsaicin 
(1%) 
Control 54.00 ± 26.30 121.80 ± 24.19 167.23 ± 53.36 
Adriamycin 
(7.5 mg/kg) 
46.55 ± 30.73  58.17 ± 22.60* 60.88 ± 16.40* 
Adriamycin 
(15 mg/kg) 
23.55 ± 19.24*  35.67 ± 12.55* 48.33 ± 27.09* 
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tissue Evans blue contents were markedly and significantly reduced to 109.93 ± 38.16, and 
51.08 ± 17.43 µg/g after the application of capsaicin (for both comparisons p<0.01, n=8; Fig. 
6f), while there was no difference in the effect of histamine-, bradykinin- and substance P–
induced plasma extravasation between control and adriamycin-treated rats (Table III). 
 
 Table III Effect of doxorubicin treatment on the plasma extravasation induced by various 
vasoactive compounds 
Evans blue 
concentration of 
the abdominal skin 
(µg/g tissue) 
Histamine 
(10 µg in 0,1 ml 
SIF) 
Bradykinin 
(4 µg in 0,1 ml 
SIF) 
 
Substance P 
(10 µg in 0,1 ml 
SIF) 
control 501.0±70.9 236.1±70.2 
115.8±35.7 
adriamycin (15 
mg/kg i.v.) 506.3±182.2 305.0±126.9 
 
125.9±136.3 
 
Data show the Evans blue dye content of standard size skin samples after the intracutaneous application of 
different vasoactive compounds. Note, that there is no significant difference between control and adriamycin 
treated rats. Data are expressed as mean ± SD, n=6-9/group 
34 
 
Fig. 6 Effects of adriamycin treatment on chemically-evoked cutaneous sensory neurogenic vasodilatation (a, c, 
d), plasma extravasation (e, f), and axonal CGRP release (b). The graph (a) demonstrates percentage changes of 
blood flow of the dorsal paw skin after the application of mustard oil (0.2 %, arrow) in control and adriamycin-
treated animals as assessed by laser Doppler flowmetry. Each marker indicates changes of blood flow measured 
in consecutive 1-min periods expressed as mean + SD of six animals. The graph (b) shows the effect of 
adriamycin treatment (cumulative dose: 15 mg/kg) on capsaicin- and high KCl-induced release of CGRP from 
rat sciatic nerves in vitro. (n = 6–8/group). The graphs (c), (d) show the effect of adriamycin treatments on 
mustard oil- and capsaicin-induced cutaneous vasodilatation. (n = 6–10/group). (e), (f) show mustard oil- and 
capsaicin-evoked plasma extravasation in control and in adriamycin-treated rats (n = 8 for each group). The 
effects of capsaicin and mustard oil were inhibited significantly by the specific TRPV1 and TRPA1 antagonists 
capsazepine and HC-030031, respectively. In graphs b–f, each marker indicates an individual value and the 
horizontal lines show the mean of the group. * Significantly different from the control, p < 0.05 
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Effects of adriamycin treatment on the in vitro neural release of CGRP 
Neurogenic sensory vasodilatation is mediated by CGRP released from 
chemosensitive afferent nerves in response to stimulation of the TRPV1 and TRPA1 receptors. 
Study of the capsaicin-induced release of CGRP is an established experimental approach 
through which to characterize the sensory efferent function of peptidergic nociceptors 
expressing the TRPV1 ion channel. Capsaicin and high potassium-induced release of CGRP 
was therefore measured with ELISA in ex vivo preparations of sciatic nerves from control and 
adriamycin-treated rats. The release of CGRP, elicited by capsaicin at concentrations of 0.1, 
1.0 and 10.0 µM, was significantly inhibited by 69.54%, 54.02 % and 23,26%, respectively, 
in the presence of the specific TRPV1 antagonist, capsazepine (10.0 µM; p<0.01, n=6/group). 
In the control sciatic nerve preparations, both capsaicin (10 μM) and high potassium (60 mM) 
elicited a marked release of CGRP (325 ± 110%, and 327 ± 77% of the basal release, 
respectively, n=6-8/group). In preparations obtained from adriamycin-treated rats, the high 
potassium-induced peptide release was similar to that in the controls (303 ± 55% of the basal 
release, n=8, n.s.). In contrast, the capsaicin-induced release of CGRP was significantly 
reduced in the adriamycin-treated animals (164 ±71% of the basal release, p<0.01, n=6; Fig. 
6b).  
 
Effects of adriamycin on carrageenan-induced thermal and mechanical hyperalgesia 
The findings on the effects of adriamycin treatment on the neurogenic sensory 
vascular responses were indicative of a marked functional impairment of the chemosensitive 
afferent nerves which express the TRPV1 and TRPA1 receptors. Since these nociceptive ion 
channels play a crucial role in the mechanism of inflammatory hyperalgesia (Caterina et al., 
2000), the effects of adriamycin treatment were studied in the carrageenan model of paw 
inflammation. In the control rats that received carrageenan, the paw withdrawal latencies to 
radiant heat stimulation decreased by 63.2 ± 2.0% (p<0.05, n=5). In contrast, in the 
adriamycin-treated rats that received carrageenan, the heat withdrawal latencies were barely 
different from the control values (16.5 ± 11.6%, n=5, n.s.). Similarly, the mechanical 
withdrawal thresholds were significantly reduced in the controls (by 61.6 ± 10.5%, p<0.05, 
n=5), but not in the adriamycin-treated animals (by 19.4 ± 7.0%, n.s., n=5; Fig. 7). 
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Fig. 7 Effect of adriamycin treatment 
(cumulative dose: 15 mg/kg) on carrageenan-
induced thermal and mechanical 
hyperalgesia. Percentage decreases in 
withdrawal responses to heat and mechanical 
stimuli are shown. Each symbol indicates the 
data of an individual animal; horizontal lines 
show the mean values of the groups (n=5 for 
each group). * Significantly different from 
the control, p<0.05. 
 
 
 
Effects of adriamycin on hindlimb locomotor parameters 
The treated animals walked in a similar manner as their intact controls.  No marked 
difference in the locomotor pattern of intact and treated animals was observed before the 
detailed analysis. In adriamycin treated rats, thorough examination of the high resolution 
images failed to reveal any significant impairment in step length, ankle and knee lifting, 
lateral placing (Fig. 8), ankle flexion and spreading of toes (n.s., n=5 ). The knee flexion, 
tarsus off angle and metatarsus-surface angle parameters showed moderate but significant 
differences for both treatment groups as compared with the controls (p<0.05, n=5).  
 
Fig. 8 Hindlimb locomotor 
parameters directly dependent on the 
integrity of motoneuron function. 
Box whisker plots showing the knee 
lifting, ankle lifting, step length and 
lateral placing parameters measured 
in control and adriamycin-treated 
rats. There is no indication of motor 
impairment after adriamycin 
treatment. (n=5 for each group). * 
Significantly different from the 
control, p<0.05 
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Effects of adriamycin treatment on cutaneous sensory nerves and on skin structure 
The effects of adriamycin treatment on the cutaneous innervation were studied with 
immunohistochemistry, quantitative stereological methods being used to determine the 
epidermal nerve fiber density of the rat plantar paw skin. In control skin samples tubulin 
immunostaining revealed subepithelial bundles of nerve fibers giving rise to individual 
epidermal axons approaching the surface. In accord with our previous findings, two 
morphological types of epidermal axons were seen: axons with simple morphology, 
exhibiting little branching and a straight course, and axons which take a tortuous course and 
develop elaborate arborization. It was earlier established that the axons with simple 
morphology are peptidergic, whereas those with complex morphology are non-peptidergic 
(Dux et al., 1998;Zylka et al., 2005). Double immunofluorescence staining revealed that 
almost all the tubulin-immunoreactive epidermal axons are TRPV1-positive. The densities of 
tubulin- and TRPV1-immunoreactive epidermal axons were 1075 ± 120 mm/mm
3 and 1065 ± 
116 mm/mm
3
,
 
respectively. The density of epidermal axons decreased by roughly half 
following adriamycin treatment; the densities of tubulin- and TRPV1-positive axons were 503 
± 76 (p<0.01, n=5) and 417 ± 80 mm/mm3 (p<0.01, n=5), respectively. Interestingly, although 
the number of epidermal axons was greatly reduced, bundles of nerve fibers were seen 
subepidermally. It appeared that the epidermal axons were truncated at the epidermal-
subepidermal border (Fig. 9.). Adriamycin treatment also resulted in a significant reduction in 
epidermal thickness (control: 70.41 ± 7.52 µm; adriamycin-treated: 47.47 ± 6.75 µm; p<0.01, 
n=5; Fig. 10).  
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Fig. 9 Effects of adriamycin treatment (cumulative dose: 15 mg/kg) on the distribution of intraepidermal 
axons of the rat plantar skin. Z-stack confocal microscopic images were taken from specimens double 
immunostained for tubulin (b,e) and TRPV1 (a,d). Note the colocalization of tubulin and TRPV1 (c,f) and 
the massive loss of intraepidermal axons after adriamycin treatment (d,e,f). Subepidermal nerves 
(arrowheads) can still be seen after adriamycin treatment (d,e,f). The scale bar in f holds for all 
microphotographs 
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Fig. 10. Z-stack confocal microscopic images 
of the plantar skin of control (a) and adriamycin-
treated (b), cumulative dose: 15 mg/kg) rats. 
Epidermal nuclei are visualized with DAPI and 
intraepidermal axons with TRPV1 
immunohistochemistry. Note the marked 
thinning of the epidermis after adriamycin 
treatment. The scale bar in b holds for both 
microphotographs. 
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DISCUSSION 
 
Evaluation of adriamycin-induced cardiac impairments using echocardiography 
Several methods are used to evaluate cardiac function under physiological and 
pathological conditions in both humans and experimental animals. Electrocardiography has 
been the standard technique for the assessment of pathophysiological changes in heart 
function (Minow and Benjamin, 1975). It has been used to detect deterioration of cardiac 
function following the administration of cardiotoxic drugs, such as adriamycin. However, ST-
T changes are neither specific nor characteristic of cardiomyopathy, and reduction of the QRS 
amplitude occurs late in the therapy (Takemura and Fujiwara, 2007). Further, these alterations 
often do not precede the clinical onset of cardiomyopathy and, therefore, they have little 
predictive value. Other techniques used to detect cardiac dysfunction include radionuclide 
angiocardiography, biochemical parameters, and histopathological grading of transvenous 
endomyocardial biopsy specimens (Billingham et al., 1978; Morandi et al., 2001; Panjrath and 
Jain, 2006). Unfortunately, these techniques lack specificity and clinical validation and/or are 
invasive (Gabrielson et al., 2008; Octavia et al., 2012). The introduction of echocardiography 
heralded the advent of a new era in the clinical and experimental investigation of heart 
function. Echocardiography, a non-invasive technique, is now generally used to evaluate 
cardiac function by measuring pivotal cardiac morphological and functional parameters 
(Parisi, 1978; Lewis et al., 1978; Friedman et al., 1979; Biancaniello et al., 1980). 
In our study, therefore, we used echocardiography as the most reliable and least 
invasive technique, which can be used for serial examinations to detect early signs of cardiac 
dysfunction and the progression of adriamycin-induced cardiomyopathy. Administration of 
adriamycin to rats over a period of two weeks resulted in a progressive deterioration of 
cardiac function as reported previously (Tong et al., 1991). Follow-up measurements of the 
cardiac parameters revealed that the changes indicative of an impaired cardiac function were 
most marked from the third week onwards after the cessation of adriamycin administration. 
The FS displayed a noteworthy reduction by three weeks after the cessation of treatment, and 
by the fourth week the reduction reached the level of statistical significance. Similarly as in 
previous reports, only minor changes in LVDD were detected in the course of the study, but 
LVSD exhibited significant increases from the third week onwards (Schwarz et al., 1998). 
The animals showed other signs of congestive heart failure, as indicated by pericardial and 
pleural effusions and ascites. These findings corroborate the earlier observations and furnish 
41 
 
further evidence that adriamycin causes a progressive deterioration of cardiac function 
resembling congestive cardiomyopathy, which can be reliably monitored by means of follow-
up echocardiographic examinations in the rat.  
 
Cardioprotective effect of chemosensitive fibers 
The most important observation in the present study was the demonstration of a 
marked aggravation and, in particular, acceleration of the development of the symptoms of 
adriamycin-induced congestive heart failure in capsaicin-pretreated rats. Hence, capsaicin 
pretreatment resulted in a marked deterioration of the cardiac function even only one week 
after the cessation of adriamycin administration, as indicated by a significant reduction in FS 
and a significant increase in the ratio LAD/AOD. In particular, one and two weeks after the 
completion of adriamycin treatment FS was significantly reduced and the ratio LAD/AOD 
was significantly increased in the capsaicin-pretreated rats as compared not only with the 
baseline values, but also with the values obtained in the rats treated only with adriamycin. 
Similarly, as in the rats treated only with adriamycin, pericardial and pleural effusions and 
ascites were observed in many animals upon ultrasonographic examination. Administration of 
capsaicin did not produce significant changes in cardiac parameters examined.  
Capsaicin is a selective sensory neurotoxin which is known to induce depletion and/or 
degeneration of somatic and visceral chemosensitive C-fiber sensory nerves (Jancsó et al., 
1977). Histochemical studies demonstrated peptide-containing sensory nerves in the heart of 
various species, including the rat (Mulderry et al., 1985; Gibbins et al., 1985). The depletion 
of CGRP-immunoreactive nerve fibers has also been demonstrated after systemic 
administration of capsaicin (Wharton et al., 1986; Ferdinandy et al., 1997). This was 
confirmed in the present study by showing a practically complete elimination of CGRP-
immunoreactive nerves in both the atria and ventricles of adriamycin-treated rats. However, a 
similar reduction in cardiac nerves visualized with PGP 9.5 immunohistochemistry was not 
observed. CGRP plays a cardinal role in the myocardial protection provided by ischemic 
preconditioning, heat stress or nitroglycerine which is dependent on the integrity of the 
capsaicin-sensitive sensory nerves and is abolished after capsaicin treatment (Ferdinandy et 
al., 1997; Song et al., 1999; Zhou et al., 2001; Wang and Wang, 2005). Accordingly, we 
suggest that the loss of capsaicin-sensitive CGRP-containing cardiac afferent nerve fibers 
may be the most likely explanation for the marked acceleration and aggravation of the 
adriamycin-induced cardiac pathology in the capsaicin-pretreated rats. Elimination of an 
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important cardioprotective mechanism by the depletion of CGRP through capsaicin 
pretreatment may result in the earlier onset and rapid progression of the myocardial changes 
leading to congestive cardiomyopathy. This assumption is supported by earlier findings 
showing the deleterious effect of sensory denervation on experimentally-induced myocardial 
ischemia, and the beneficial effect of CGRP in experimental models of cardiac ischemia and 
arrhythmia (Kallner and Franco-Cereceda, 1989; Csont et al., 2003). Taken together, these 
observations strongly suggest that local release of sensory neuropeptides, in particular CGRP, 
from capsaicin-sensitive afferent nerves may be a significant protective mechanism which 
counteracts the deleterious effects of adriamycin in this experimental model of congestive 
cardiomyopathy. Since capsaicin acts through the activation of the TRPV1 receptor, these 
findings also suggest an implication of this nociceptive ion channel in the mechanisms of 
cardioprotection conferred by chemosensitive afferent nerves expressing the TRPV1 receptor. 
Importantly, the expression of TRPV1 receptor has been demonstrated in cardiac sensory 
nerves (Zahner et al., 2003). This assumption is supported by recent findings which 
demonstrated that postischemic recovery is impaired in TRPV1 gene knockout mice (Wang 
and Wang, 2005). On the contrary, activation of the TRPV1 receptor through N-
oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-
reperfusion injury (Zhong and Wang, 2008). 
In addition, other mechanisms may also contribute to cardioprotection afforded by 
capsaicin-sensitive afferent nerves. Hence, stimulation of capsaicin-sensitive afferents has 
been suggested to exert a protective effect by triggering cardiogenic sympathoexcitatory 
reflexes (Zahner et al., 2003). Further, endocrine mechanisms may also contribute to the 
cardioprotective effect of capsaicin-sensitive afferent nerves. Hence, B-type natriuretic 
peptide has been shown to limit the size of ischemia-induced infarcts in isolated rat hearts 
(D'Souza et al., 2004) and the stretch-induced release of atrial natriuretic peptide has been 
shown to be inhibited in capsaicin treated rats (Rankin and Scott, 1990). 
In conclusion, the present study has demonstrated that elimination of capsaicin-
sensitive afferent nerves promote the development and progression of adriamycin-induced 
myocardial dysfunction. The results suggest that perturbation of the function of capsaicin-
sensitive afferent nerves and/or myocardial CGRP metabolism, e.g. by agents interfering with 
capsaicin/TRPV1 receptors localized on cardiac sensory nerves, or with peptide metabolism, 
may open up new perspectives as concerns prevention and/or alleviation of the pathological 
changes that follow adriamycin treatment. 
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Effects of adriamycin on cutaneous sensory nerve functions 
Our studies indicated that the sensory nerves which express the archetypal nociceptive 
ion channel TRPV1 and contain the neuropeptide CGRP exert a protective effect against 
adriamycin-induced cardiotoxicity in a rat model of congestive cardiomyopathy. These 
observations suggested the possibility that the neurotoxic propensity of this anthracycline-
type cytotoxic agent may play a role in the development of cardiac pathologies by virtue of 
their neurotoxic effect through the elimination of an important cardioprotective mechanism 
conferred by the sensory nerves. The effects of antitumor agents on sensory functions have 
been the subject of extensive investigations (Grisold et al., 2012), but studies on the effects of 
these compounds on nociceptor functions are scarce. In subsequent studies, therefore, we 
sought to further explore the effects of adriamycin on sensory nerve functions. Since 
somatosensory and visceral chemosensitive nerves share common functional characteristics, 
our studies related to the effects of adriamycin on the morphology and function of cutaneous 
afferent nerves, whose morphological and functional traits are best characterized (Roosterman 
et al., 2006; Jancsó et al., 2009a). Hence, through application of a treatment paradigm 
previously shown to produce congestive cardiomyopathy in the rat, we have explored the 
possible neurotoxic effects of adriamycin on cutaneous chemosensitive afferent nerves 
through studies of cutaneous neurogenic sensory vasodilatation, neurogenic plasma 
extravasation, inflammatory hyperalgesia, cutaneous innervation, and measurement of CGRP 
release from sensory nerves. 
We demonstrated that adriamycin treatment resulted in a marked reduction of both 
components of the cutaneous neurogenic inflammatory response, e.g. vasodilatation and 
plasma extravasation elicited by chemical irritants. Mustard oil and capsaicin applied onto the 
skin acts by directly activating TRPA1 and TRPV1 receptors, respectively. TRPV1 and 
TRPA1 are expressed mostly by the same population of chemosensitive afferents (Jordt et al., 
2004; Bautista et al., 2005; Kobayashi et al., 2005; Nagata et al., 2005). Activation of 
epidermal chemosensitive fibers leads to the release of vasoactive sensory peptides. SP is 
responsible for plasma extravasation by binding to NK1 receptors situated on endothelial cells 
of postcapillary venules (Lembeck and Holzer, 1979; Kenins et al., 1984; Chahl, 1988), while 
CGRP exerts its vasodilatory effect mostly by directly acting on vascular smooth muscle cells 
(Ralevic et al., 1992). They are stored in the sensory nerve endings and can be released via 
TRPV1 or TRPA1 mediated mechanisms (Pethő et al., 2004) Irritant-induced neurogenic 
vasodilatation is mediated by chemosensitive afferent nerves and both non-selective and 
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selective (capsaicin-induced) denervation of the skin abolishes it completely (Jancsó et al., 
1977). Neurogenic sensory vasodilatation is a sensitive measure of sensory nerve function 
since activation of even one single nerve fiber can cause detectable changes in CuBF (Lynn et 
al., 1996). Investigation of the cutaneous flare response, the human equivalent of neurogenic 
sensory vasodilatation was proposed as a diagnostic tool to assess the functionality of C-fiber 
(cutaneous) afferents (Jancsó and Janka, 1981; Jancsó et al., 1983; Baron et al., 1988; Husz et 
al., 1991; Baron et al., 1999). In our experiments we found that epicutaneous application of 
chemical irritants produced a transient dose-dependent increase in regional CuBF which was 
significantly reduced following adriamycin treatment. Quantitative measurement of 
neurogenic plasma protein extravasation both in response to epicutaneous administration of 
capsaicin or mustard oil showed similar dramatic decreases in adriamycin-treated animals. At 
the same time, permeability changes induced by chemical agents acting directly on blood 
vessels were unaffected, which suggest that vascular responsiveness is unaffected by 
adriamycin. These findings indicated that the local regulatory, sensory-efferent functions of 
nociceptive sensory nerves are profoundly affected by adriamycin treatment. Since these 
efferent responses are mediated by vasoactive peptides released from activated sensory 
nerves, we measured the capsaicin-induced release of CGRP in peripheral nerves obtained 
from control and adriamycin-treated rats using ELISA. The results disclosed a significant 
decrease of the capsaicin-evoked release of CGRP from sciatic nerves. High potassium-
induced release of CGRP was unaffected by adriamycin treatment, suggesting an impairment 
of mechanisms involved in the activation of the TRPV1 receptor.  
Inflammatory hyperalgesia is a sensitive measure of classical nociceptor function. The 
examination of heat and mechanical nociceptive responses revealed a marked attenuation of 
carrageenan-induced inflammatory hyperalgesia in adriamycin-treated rats. This suggests an 
impairment of the afferent, nociceptive function of chemosensitive sensory nerves expressing 
the TRPV1/TRPA1 receptors, which have been shown to be critically involved in the 
mechanism of inflammatory hyperalgesia (Davis et al., 2000; Pogatzki-Zahn et al., 2005). The 
results of the quantitative locomotor analysis failed to reveal major motor impairments in 
adriamycin treated rats. Except three parameters all measurements yielded results similar to 
the controls. Locomotor parameters directly dependent on the integrity of spinal motoneuron 
function, such as step length, ankle and knee lifting and lateral placing remained unaffected 
by the treatment (Nógrádi et al., 2007; Pájer et al., 2014). The significant differences observed 
in parameters tarsus off angle, metatarsus-surface angle and knee flexion, suggest 
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disturbances in proprioception rather than a true impairment of motor function. Hence, the 
increased latency of the nociceptive withdrawal reflex following the administration of 
carrageenan in adriamycin-treated animals may be attributed to a toxic damage of the 
antitumor agent on nociceptive afferent nerves, rather than an impairment of motor 
function/performance.  
The mechanisms of the impairments in both the classical afferent, nociceptive and 
sensory-efferent, local vascular functions of chemosensitive afferent nerves expressing the 
TRPV1 and TRPA1 receptors cannot be fully explained on the basis of the present findings. 
However, the results do indicate that degenerative changes of cutaneous, and in particular 
epidermal sensory axons may be responsible, at least partially, for these functional 
disturbances. Examination of cutaneous innervation by means of immunohistochemistry and a 
quantitative stereological approach revealed a marked loss of epidermal axons in adriamycin-
treated animals. In contrast, the density and distribution of subepidermal nerve fibers 
appeared normal, suggesting a selective loss of epidermal nerve endings. This might explain 
both the marked reduction of the sensory neurogenic vascular reactions and the inflammatory 
hyperalgesia in adriamycin-treated rats, since activation of the epidermal chemosensitive 
nerves is essential in the initiation of these responses (Maggi and Meli, 1988; Szolcsányi, 
1988; Holzer, 1998b; Davis et al., 2000; Caterina et al., 2000; Jancsó et al., 2009a). It is 
noteworthy that similar structural changes, i.e. a selective loss of terminal, epidermal, but not 
preterminal nerve fibers was also observed in the toxic neuropathies elicited by paclitexel 
(Boyette-Davis et al., 2011) and vincristine (Siau et al., 2006) and, interestingly, a human 
bacterial disease, leprosy (Miko et al., 1993).   
Epidermal thinning was pronounced after the administration of adriamycin. This may 
well be explained by a direct antiproliferative action of the drug on the germinative cells of 
the epidermis, but the contribution of neuronal mechanisms cannot be excluded. Indeed, 
sensory denervation-induced thinning of the plantar skin has been demonstrated in the rat 
(Chiang et al., 1998). Hence, the marked loss of epidermal axons observed in the present 
study may also play a role in this phenomenon.  
In conclusion, the findings presented in this thesis have demonstrated the protective 
role of TRPV1 expressing chemosensitive afferent nerves in a clinically important 
pathological entity, anthracycline-induced dilatative cardiomyopathy. Further, these 
observations support and extend previous reports on cardioprotective neurogenic mechanisms 
involving a specific class of nociceptive peptidergic CGRP-containing sensory nerves which 
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express the nociceptive ion channels TRPV1 and TRPA1. We also provided evidence for a 
neurotoxic lesion by adriamycin of nociceptive primary sensory neurons resulting in profound 
impairments in nociceptive functions of fundamental physiological and pathophysiological 
significance, such as pain sensation and neurogenic sensory vascular reactions. The findings 
also suggest that the neurotoxic propensity of anthracycline-type antitumor agents may 
contribute to the deterioration of cardiac function through the elimination of an important 
cardioprotective mechanism conferred by sensory nerves. Importantly, the adriamycin-
induced functional impairments of the nociceptive afferent neurons observed in the present 
study precede the commencement of cardiomyopathic changes. Hence, the findings raise the 
possibility of using specific quantitative sensory testing, such as the detection and 
quantification of the axon reflex flare response, the human equivalent of neurogenic sensory 
vasodilatation, to predict the risk of adriamycin-induced cardiac injury in clinical practice. 
Taking into consideration that adriamycin- cardiomyopathy once developed carries a poor 
prognosis and has no definitive treatment at the moment, cutaneous sensory tests as tools for 
the prediction of cardiac damage could open a door for the more effective preventive 
cardioprotective therapies. 
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The specific conclusions of this study were as follows: 
1) Chemosensitive cardiac sensory nerves play a crucial protective role against the chronic 
cardiotoxic effect of anthracyclines in the rat model. Systemic capsaicin pretreatment 
intensify and accelerate the development of cardiomyopathy. 
2) Adriamycin treatment severely impairs TRPV1/TRPA1-mediated afferent and efferent 
cutaneous sensory nociceptive functions, dramatically decreases epidermal nerve fiber density 
and causes significant epidermal thinning. Adriamycin treatment decreases capsaicin-induced 
CGRP release from peripheral nerves, while depolarization-induced CGRP release remains 
intact. Adriamycin-induced sensory changes appear prior to the manifestation of the 
cardiotoxic effect. 
3) Present study raises the possibility of functional sensory testing as a predictive monitoring 
tool in anthracycline-induced cardiomyopathy. Our results highlight the potential usefulness 
of testing cutaneous neurogenic vascular reactions, such as the detection and quantification of 
the axon reflex flare response to predict the risk of adriamycin-induced cardiac injury in 
clinical practice. 
4) The severe toxic effect of adriamycin on cutaneous chemo-nociceptive fibers suggests that 
sensory neural deficit could play a role in the pathomechanism of adriamycin-cardiotoxicity. 
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SUMMMARY 
 
Selye’s (1936) recognition of the “general adaptation syndrome”, later renamed by 
Selye “stress response” not only initiated a still growing wave of medical research, but also 
raised the idea, that diverse injury can activate the same coping systems of the body or an 
organ. Chemo-nociceptors, that innervate most organs including the skin and the heart, exert 
nociceptive afferent and local regulatory efferent functions by releasing sensory 
neuropeptides, and express the TRPV1 and/or TRPA1 receptor, can be considered as an 
important innate coping system for heterogeneous noxa.  
In this study, we examined the possible protective role of CGRP containing 
chemosensitive afferent nerves in an established model of adriamycin-induced experimental 
cardiomyopathy in rats. Systemic treatment with capsaicin was utilized to deplete sensory 
neuropeptides from cardiac afferent nerves. Echocardiography was applied to assess the 
cardiac function in adriamycin-treated rats pretreated with capsaicin or its vehicle. In control 
rats, adriamycin treatment produced a reduction in the fractional shortening of the left 
ventricle and an increase in the ratio of the left atrial diameter and the aortic diameter, 
indicative of a decreased myocardial contractility and heart failure at 3–4 weeks post-
treatment. In contrast, in capsaicin-pretreated rats, a deterioration of the cardiac function was 
already evident 1 week after the cessation of adriamycin administration, while the clinical 
signs associated with cardiomyopathy were more severe and displayed a significantly more 
rapid progression. Immunohistochemistry revealed a complete depletion of calcitonin gene-
related peptide from cardiac sensory nerves after systemic capsaicin treatment.  
Besides their deleterious action on cardiac muscle, anthracycline-type cytostatic agents 
exert significant neurotoxic effects on primary sensory neurons. Therefore, we also examined 
the effects of cardiotoxic doses of adriamycin on the function and morphology of epidermal 
nerves, that share common traits with cardiac chemosensitive nerves. Sensory neurogenic 
vasodilatation, plasma extravasation and the neural CGRP release evoked by TRPV1 and 
TRPA1 agonists in vitro were examined by using laser Doppler flowmetry, the Evans blue 
technique and ELISA, respectively. Carrageenan-induced hyperalgesia was assessed with the 
Hargreaves method. Immunohistochemistry was utilized to study cutaneous innervation. 
Adriamycin treatment resulted in profound reductions in the cutaneous neurogenic sensory 
vasodilatation and plasma extravasation evoked by the TRPV1 and TRPA1 agonists capsaicin 
and mustard oil, respectively. The in vitro capsaicin-, but not high potassium-evoked neural 
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release of the major sensory neuropeptide, CGRP, was markedly attenuated after adriamycin 
treatment. Carrageenan-induced inflammatory hyperalgesia was largely abolished following 
the administration of adriamycin. Immunohistochemistry revealed a substantial loss of 
epidermal TRPV1-expressing nociceptive nerves and a marked thinning of the epidermis.  
The results suggest that TRPV1-expressing cardiac peptidergic nerves have a 
protective role against anthracycline-induced cardiac pathologies. Furthermore, these findings 
indicate early impairments in the functions of TRPV1 and TRPA1 receptors expressed on 
cutaneous chemosensitive nociceptive nerves and the loss of epidermal axons following the 
administration of cardiotoxic doses of adriamycin. 
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